data_1bc6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bc6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.494 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.425 ' CG2' HG21 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.893 0.378 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.415 ' CG2' HG23 ' A' ' 60' ' ' VAL . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 ' CG2' HG23 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.518 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG23 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.51 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG2' HD22 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-O 121.435 0.636 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.411 HD22 ' CG2' ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.409 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.406 ' CG2' HG23 ' A' ' 60' ' ' VAL . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' CG2' ' A' ' 5' ' ' THR . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.464 ' CG2' HG23 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' ' 72' ' ' ARG . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.448 HH12 ' CD ' ' A' ' 57' ' ' GLU . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.443 ' CG2' HG23 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.558 0.218 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.446 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 . . . . . 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 120.983 0.42 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.431 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.813 0.339 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 119.853 -0.118 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.425 ' CG2' HG21 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.61 15.83 13.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -107.12 100.02 9.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.354 1.077 . . . . 0.0 108.866 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 60.93 -156.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.077 1.751 . . . . 0.0 113.283 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -153.63 173.19 16.11 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.84 2.056 . . . . 0.0 106.973 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.017 1.727 . . . . 0.0 113.254 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 p 55.62 38.5 30.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.569 1.948 . . . . 0.0 113.309 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -166.9 -53.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 108.652 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -114.19 14.09 18.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -35.96 4.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.335 0.654 . . . . 0.0 110.623 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.444 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.778 -149.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.7 21.98 45.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -70.65 -55.44 8.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.1 1.45 . . . . 0.0 110.988 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -152.21 156.66 40.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.498 1.119 . . . . 0.0 108.588 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -56.1 172.7 0.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.089 1.355 . . . . 0.0 111.488 159.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -8.22 102.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.485 2.714 . . . . 0.0 114.664 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -144.67 177.75 8.47 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p 58.5 -50.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.366 2.666 . . . . 0.0 115.039 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -121.06 22.34 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 -44.13 2.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.822 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 126.423 1.889 . . . . 0.0 107.948 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.27 -25.18 8.21 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.4 m -65.68 -37.6 86.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.762 1.781 . . . . 0.0 111.418 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt 58.95 -101.59 0.13 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.087 1.355 . . . . 0.0 112.082 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.74 68.55 3.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.802 0.441 . . . . 0.0 110.172 -158.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.24 164.32 12.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 110.053 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.2 m -66.35 -6.69 15.07 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -158.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -49.03 -39.65 27.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.89 1.223 . . . . 0.0 110.739 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.22 32.52 5.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 73' ' ' ASP . 1.4 tppt? -67.68 175.0 3.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.896 1.331 . . . . 0.0 110.286 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.431 -1.413 0 C-N-CA 128.393 2.677 . . . . 0.0 104.987 -154.628 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.415 ' CG2' HG23 ' A' ' 60' ' ' VAL . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.81 6.22 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -82.65 117.46 22.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.095 -0.65 . . . . 0.0 109.977 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -108.31 167.12 10.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 155.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 49.74 61.58 3.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.606 1.562 . . . . 0.0 112.931 161.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.55 153.3 49.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -76.53 56.72 1.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p -87.56 -21.37 25.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 150.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -129.06 38.7 3.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -90.63 159.3 16.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 122.386 1.089 . . . . 0.0 111.217 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.461 0 C-N-CA 128.806 2.843 . . . . 0.0 104.293 -149.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.82 -48.31 2.64 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 67.08 0.33 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.339 1.856 . . . . 0.0 111.879 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -72.11 76.93 0.95 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.154 -0.966 . . . . 0.0 108.847 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.77 -74.56 0.27 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 110.249 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.74 177.02 5.26 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.745 1.259 . . . . 0.0 113.569 -161.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m -73.66 52.58 0.4 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.808 2.043 . . . . 0.0 113.808 -172.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p -82.63 100.72 10.35 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 153.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.87 31.26 6.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -141.72 -160.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 148.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.87 25.03 3.41 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -103.1 127.44 50.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.813 1.307 . . . . 0.0 110.1 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 58.84 -155.11 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.554 1.942 . . . . 0.0 114.589 168.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -89.22 -163.59 1.02 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.621 2.369 . . . . 0.0 109.292 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.82 -81.09 0.12 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.007 0.923 . . . . 0.0 111.174 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.3 -50.9 0.68 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.861 1.264 . . . . 0.0 113.271 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.43 -28.68 31.19 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -121.81 30.0 6.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -82.1 165.25 20.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.751 1.263 . . . . 0.0 111.704 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.446 0 C-N-CA 129.059 2.943 . . . . 0.0 104.344 -150.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' CG2' HG23 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.31 4.11 88.86 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.7 p -71.71 -62.41 1.43 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.829 1.815 . . . . 0.0 108.59 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 tptt 58.97 47.61 11.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.61 1.564 . . . . 0.0 110.146 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.54 -178.61 6.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.59 -9.87 13.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.779 1.632 . . . . 0.0 111.317 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -54.26 -52.17 62.21 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p -73.09 -46.96 48.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.6 15.35 22.94 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -114.94 -55.22 2.5 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.059 0.944 . . . . 0.0 110.951 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.833 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.518 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG23 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.35 -24.78 8.99 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -82.62 58.84 4.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.968 1.384 . . . . 0.0 111.896 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -33.32 39.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.005 0.522 . . . . 0.0 111.709 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -39.74 -41.05 1.04 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 127.901 2.48 . . . . 0.0 112.784 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.26 67.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.867 0.467 . . . . 0.0 112.186 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m 70.71 64.74 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.065 1.346 . . . . 0.0 113.743 164.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p -78.11 -49.1 14.56 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.594 160.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 -128.02 38.44 4.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.8 -43.36 0.82 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.459 0.572 . . . . 0.0 111.3 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.202 0 C-N-CA 126.116 1.766 . . . . 0.0 107.795 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.411 ' CG2' HD22 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.06 -49.44 0.85 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -61.63 157.4 17.62 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.924 1.362 . . . . 0.0 112.252 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -143.23 -49.47 0.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.297 1.839 . . . . 0.0 108.102 158.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -18.89 -74.03 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.632 3.173 . . . . 0.0 113.894 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -40.59 -47.3 2.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.243 1.417 . . . . 0.0 113.524 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m 57.7 74.08 0.44 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p -71.92 44.65 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.435 1.494 . . . . 0.0 111.467 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.411 HD22 ' CG2' ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.59 22.28 14.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -143.6 88.14 1.98 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' CG2' HG23 ' A' ' 60' ' ' VAL . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.09 -26.47 6.74 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m 45.78 82.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.839 1.655 . . . . 0.0 112.711 169.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' NZ ' ' S4 ' ' A' ' 78' ' ' F3S . 1.1 pptp? -76.75 176.48 8.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.861 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.3 -92.06 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.336 2.654 . . . . 0.0 114.504 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.96 111.0 1.97 Allowed 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.2 m -114.69 144.68 43.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.692 0.758 . . . . 0.0 112.417 -160.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p -35.44 -42.95 0.23 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.572 2.349 . . . . 0.0 112.534 171.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' CG2' ' A' ' 5' ' ' THR . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -112.35 23.41 13.66 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -146.77 66.44 1.17 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--O 1.253 1.275 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 174.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . 0.482 ' S4 ' ' NZ ' ' A' ' 12' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.464 ' CG2' HG23 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.27 80.36 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 m 75.91 164.29 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.944 1.297 . . . . 0.0 110.251 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 163.78 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.462 1.505 . . . . 0.0 107.795 168.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -44.95 -65.28 0.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.811 2.045 . . . . 0.0 113.218 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.8 64.13 1.75 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.281 1.033 . . . . 0.0 109.967 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.16 155.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.753 0.821 . . . . 0.0 112.097 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -79.27 -64.49 1.17 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.675 1.19 . . . . 0.0 109.815 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' ' 72' ' ' ARG . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.448 HH12 ' CD ' ' A' ' 57' ' ' GLU . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -107.45 15.16 25.15 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -81.47 -33.35 32.04 Favored 'General case' 0 C--N 1.335 -0.045 0 O-C-N 122.047 -0.408 . . . . 0.0 111.591 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 C-N-CA 127.157 2.183 . . . . 0.0 106.861 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.443 ' CG2' HG23 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.83 -16.04 26.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m 73.66 83.84 0.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.435 1.894 . . . . 0.0 108.684 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -56.96 -66.15 0.5 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -165.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.79 -96.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -155.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.39 156.55 37.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.506 1.146 . . . . 0.0 113.562 -165.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -90.13 67.98 7.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.856 1.262 . . . . 0.0 110.506 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -40.7 -46.91 2.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.859 0.864 . . . . 0.0 111.247 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.88 -4.31 15.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.253 11.6 tppt? -10.36 -108.4 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -130.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.446 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.36 -27.2 4.18 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -64.21 -41.81 96.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.049 1.425 . . . . 0.0 107.324 162.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 80.89 -58.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 150.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.83 113.62 11.06 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.716 1.206 . . . . 0.0 109.447 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.85 169.97 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.669 0.788 . . . . 0.0 108.978 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -74.84 36.46 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -159.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p -70.26 -51.64 29.05 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 161.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.448 ' CG ' ' HZ3' ' A' ' 77' ' ' LYS . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 -125.17 16.14 8.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 132.18 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.234 0.925 . . . . 0.0 110.415 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HZ3' ' CG ' ' A' ' 73' ' ' ASP . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.363 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 163.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 12.49 59.01 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m 63.97 57.09 1.35 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -60.45 106.97 0.6 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.552 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 85.76 -60.7 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.514 2.725 . . . . 0.0 111.754 165.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.66 -161.73 1.16 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.785 1.234 . . . . 0.0 108.999 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.7 t -143.89 164.81 29.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p -108.34 9.4 27.83 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.12 2.168 . . . . 0.0 110.544 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -112.16 16.25 20.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -111.58 -35.79 5.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.314 1.046 . . . . 0.0 111.131 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -146.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.51 -26.81 18.08 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -68.46 -56.14 9.41 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.116 0.958 . . . . 0.0 109.249 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 65.85 -64.34 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.346 1.858 . . . . 0.0 113.794 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -108.38 89.37 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.449 1.1 . . . . 0.0 109.69 -169.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.04 -157.95 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -42.12 -36.56 1.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 128.001 2.52 . . . . 0.0 116.417 -163.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p -68.83 -19.52 64.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.66 1.184 . . . . 0.0 112.174 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.29 31.88 6.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -154.42 97.85 2.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.314 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.382 2.673 . . . . 0.0 116.123 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.446 ' CG2' HG23 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.23 4.49 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m -49.04 142.41 6.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.646 1.179 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HZ2' ' CG ' ' A' ' 30' ' ' ASP . 37.8 mmtm -141.62 94.44 2.68 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.44 -164.25 1.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 156.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.43 -27.17 3.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.916 2.086 . . . . 0.0 109.272 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.2 m -42.77 -47.26 5.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -66.98 -38.14 85.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.553 ' CG ' ' HZ2' ' A' ' 12' ' ' LYS . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 -110.36 12.13 23.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -108.16 -38.97 5.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.302 1.041 . . . . 0.0 110.734 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 115.897 -2.001 . . . . 0.0 108.224 -146.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.69 -48.0 0.98 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -63.2 131.06 47.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -134.46 26.15 3.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.483 1.513 . . . . 0.0 108.92 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.16 -111.15 0.27 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -154.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.83 162.72 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.342 1.857 . . . . 0.0 106.258 -175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 146.13 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 130.106 3.362 . . . . 0.0 108.837 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -81.23 -49.76 10.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.758 0.423 . . . . 0.0 111.227 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -110.11 44.21 1.26 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -150.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.069 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.426 -1.673 0 C-N-CA 131.673 3.989 . . . . 0.0 104.465 -169.419 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.87 -7.46 55.22 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m 54.29 46.05 25.98 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.542 1.171 . . . . 0.0 108.118 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.44 19.14 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -156.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -126.81 -88.12 0.57 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.698 0.799 . . . . 0.0 109.554 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.59 -106.89 0.09 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.649 0.38 . . . . 0.0 110.34 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -165.37 143.13 5.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p -130.0 4.32 4.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.548 1.939 . . . . 0.0 110.783 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -119.51 -9.44 9.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -72.14 -40.25 68.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.765 1.626 . . . . 0.0 110.526 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.561 2.344 . . . . 0.0 106.878 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 -32.11 2.53 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -74.91 69.97 1.92 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.818 1.247 . . . . 0.0 109.613 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.64 78.74 2.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.603 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.06 -159.68 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 168.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.63 -4.79 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 111.766 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 m -57.56 -42.29 82.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 112.598 -172.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.5 p -71.68 -51.94 20.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.089 0.404 . . . . 0.0 111.205 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.42 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 42' ' ' CYS . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.479 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 -121.03 14.47 11.47 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.72 -36.09 3.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.868 0.467 . . . . 0.0 111.295 -170.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HZ1' ' CG ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.864 -152.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.08 4.81 23.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.8 m -69.83 -46.08 66.4 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.155 1.478 . . . . 0.0 110.961 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.13 163.91 31.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -70.92 -174.7 0.98 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.919 1.288 . . . . 0.0 109.247 162.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -21.43 117.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.729 2.412 . . . . 0.0 114.066 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.434 ' HB2' ' S4 ' ' A' ' 78' ' ' F3S . 4.0 m -149.05 -37.41 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.534 0.734 . . . . 0.0 112.41 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p -106.61 23.26 14.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 112.158 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -122.13 21.14 10.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -34.86 3.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.212 1.005 . . . . 0.0 111.271 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.674 -1.632 . . . . 0.0 107.363 -153.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' F3S . . . . . 0.434 ' S4 ' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.53 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 41' ' ' ASP 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 18.3 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 3' ' ' VAL . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 68' ' ' ILE . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.452 HD21 HG22 ' A' ' 4' ' ' ILE . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG22 ' A' ' 60' ' ' VAL . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.893 0.378 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' PHE . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 3' ' ' VAL . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.434 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 26' ' ' HIS . 16.1 m-85 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 60' ' ' VAL . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.629 ' CG2' HG22 ' A' ' 60' ' ' VAL . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 6' ' ' GLU . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 33' ' ' TYR . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 28' ' ' GLY . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.629 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 36' ' ' PRO 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.411 ' CG2' HG22 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.558 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.605 ' HB2' HD12 ' A' ' 25' ' ' ILE . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 20' ' ' CYS . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.407 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-O 121.435 0.636 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.615 HD21 HG22 ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' TYR . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' ILE . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.477 ' CG2' HG22 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 18' ' ' GLU 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 17' ' ' VAL . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 2' ' ' TYR . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 4' ' ' ILE . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.558 0.218 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.46 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 36' ' ' PRO . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD21 ' A' ' 71' ' ' ASN . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.44 HD21 HG22 ' A' ' 4' ' ' ILE . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 . . . . . 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 71' ' ' ASN . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 6' ' ' GLU . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 120.983 0.42 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 4' ' ' ILE . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 HD21 ' A' ' 71' ' ' ASN . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 68' ' ' ILE . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.576 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.477 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.477 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 68' ' ' ILE . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 HD21 ' A' ' 71' ' ' ASN . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.813 0.339 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.508 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HA ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 4' ' ' ILE . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.504 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 19' ' ' VAL . 27.5 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 119.853 -0.118 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 16' ' ' CYS . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.504 HD21 HG22 ' A' ' 4' ' ' ILE . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 68' ' ' ILE . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.707 HG22 HD21 ' A' ' 71' ' ' ASN . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 31' ' ' GLN . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 9' ' ' ILE . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 68' ' ' ILE . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HA ' HD13 ' A' ' 68' ' ' ILE . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.577 ' CD1' HG11 ' A' ' 60' ' ' VAL . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.707 HD21 HG22 ' A' ' 4' ' ' ILE . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.61 15.83 13.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -107.12 100.02 9.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.354 1.077 . . . . 0.0 108.866 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 60.93 -156.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.077 1.751 . . . . 0.0 113.283 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -153.63 173.19 16.11 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.84 2.056 . . . . 0.0 106.973 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.017 1.727 . . . . 0.0 113.254 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 p 55.62 38.5 30.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.569 1.948 . . . . 0.0 113.309 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -166.9 -53.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 108.652 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -114.19 14.09 18.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -35.96 4.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.335 0.654 . . . . 0.0 110.623 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.778 -149.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 41' ' ' ASP 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.7 21.98 45.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -70.65 -55.44 8.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.1 1.45 . . . . 0.0 110.988 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -152.21 156.66 40.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.498 1.119 . . . . 0.0 108.588 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -56.1 172.7 0.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.089 1.355 . . . . 0.0 111.488 159.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -8.22 102.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.485 2.714 . . . . 0.0 114.664 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -144.67 177.75 8.47 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p 58.5 -50.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.366 2.666 . . . . 0.0 115.039 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 18.3 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 3' ' ' VAL . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 68' ' ' ILE . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.452 HD21 HG22 ' A' ' 4' ' ' ILE . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -121.06 22.34 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 -44.13 2.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.822 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 126.423 1.889 . . . . 0.0 107.948 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG22 ' A' ' 60' ' ' VAL . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.27 -25.18 8.21 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.4 m -65.68 -37.6 86.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.762 1.781 . . . . 0.0 111.418 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt 58.95 -101.59 0.13 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.087 1.355 . . . . 0.0 112.082 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.74 68.55 3.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.802 0.441 . . . . 0.0 110.172 -158.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.24 164.32 12.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 110.053 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.2 m -66.35 -6.69 15.07 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -158.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -49.03 -39.65 27.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.89 1.223 . . . . 0.0 110.739 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' PHE . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 3' ' ' VAL . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.434 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 26' ' ' HIS . 16.1 m-85 -121.22 32.52 5.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -67.68 175.0 3.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.896 1.331 . . . . 0.0 110.286 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.431 -1.413 0 C-N-CA 128.393 2.677 . . . . 0.0 104.987 -154.628 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.81 6.22 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -82.65 117.46 22.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.095 -0.65 . . . . 0.0 109.977 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -108.31 167.12 10.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 155.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 49.74 61.58 3.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.606 1.562 . . . . 0.0 112.931 161.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.55 153.3 49.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -76.53 56.72 1.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p -87.56 -21.37 25.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 150.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -129.06 38.7 3.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -90.63 159.3 16.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 122.386 1.089 . . . . 0.0 111.217 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.461 0 C-N-CA 128.806 2.843 . . . . 0.0 104.293 -149.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 60' ' ' VAL . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.82 -48.31 2.64 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 67.08 0.33 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.339 1.856 . . . . 0.0 111.879 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -72.11 76.93 0.95 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.154 -0.966 . . . . 0.0 108.847 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.77 -74.56 0.27 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 110.249 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.74 177.02 5.26 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.745 1.259 . . . . 0.0 113.569 -161.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m -73.66 52.58 0.4 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.808 2.043 . . . . 0.0 113.808 -172.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p -82.63 100.72 10.35 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 153.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.87 31.26 6.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -141.72 -160.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 148.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.629 ' CG2' HG22 ' A' ' 60' ' ' VAL . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 6' ' ' GLU . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.87 25.03 3.41 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -103.1 127.44 50.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.813 1.307 . . . . 0.0 110.1 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 58.84 -155.11 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.554 1.942 . . . . 0.0 114.589 168.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -89.22 -163.59 1.02 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.621 2.369 . . . . 0.0 109.292 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.82 -81.09 0.12 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.007 0.923 . . . . 0.0 111.174 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.3 -50.9 0.68 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.861 1.264 . . . . 0.0 113.271 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.43 -28.68 31.19 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 33' ' ' TYR . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 28' ' ' GLY . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.629 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -121.81 30.0 6.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -82.1 165.25 20.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.751 1.263 . . . . 0.0 111.704 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.446 0 C-N-CA 129.059 2.943 . . . . 0.0 104.344 -150.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 36' ' ' PRO 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.411 ' CG2' HG22 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.31 4.11 88.86 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.7 p -71.71 -62.41 1.43 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.829 1.815 . . . . 0.0 108.59 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 tptt 58.97 47.61 11.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.61 1.564 . . . . 0.0 110.146 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.54 -178.61 6.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.59 -9.87 13.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.779 1.632 . . . . 0.0 111.317 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -54.26 -52.17 62.21 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p -73.09 -46.96 48.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.6 15.35 22.94 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -114.94 -55.22 2.5 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.059 0.944 . . . . 0.0 110.951 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.833 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.558 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.35 -24.78 8.99 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -82.62 58.84 4.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.968 1.384 . . . . 0.0 111.896 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -33.32 39.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.005 0.522 . . . . 0.0 111.709 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -39.74 -41.05 1.04 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 127.901 2.48 . . . . 0.0 112.784 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.26 67.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.867 0.467 . . . . 0.0 112.186 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m 70.71 64.74 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.065 1.346 . . . . 0.0 113.743 164.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p -78.11 -49.1 14.56 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.594 160.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.605 ' HB2' HD12 ' A' ' 25' ' ' ILE . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 20' ' ' CYS . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.407 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 -128.02 38.44 4.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.8 -43.36 0.82 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.459 0.572 . . . . 0.0 111.3 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.202 0 C-N-CA 126.116 1.766 . . . . 0.0 107.795 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.06 -49.44 0.85 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -61.63 157.4 17.62 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.924 1.362 . . . . 0.0 112.252 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -143.23 -49.47 0.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.297 1.839 . . . . 0.0 108.102 158.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -18.89 -74.03 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.632 3.173 . . . . 0.0 113.894 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -40.59 -47.3 2.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.243 1.417 . . . . 0.0 113.524 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m 57.7 74.08 0.44 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p -71.92 44.65 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.435 1.494 . . . . 0.0 111.467 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.615 HD21 HG22 ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.59 22.28 14.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -143.6 88.14 1.98 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.09 -26.47 6.74 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m 45.78 82.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.839 1.655 . . . . 0.0 112.711 169.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' NZ ' ' S4 ' ' A' ' 78' ' ' F3S . 1.1 pptp? -76.75 176.48 8.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.861 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.3 -92.06 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.336 2.654 . . . . 0.0 114.504 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.96 111.0 1.97 Allowed 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.2 m -114.69 144.68 43.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.692 0.758 . . . . 0.0 112.417 -160.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p -35.44 -42.95 0.23 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.572 2.349 . . . . 0.0 112.534 171.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -112.35 23.41 13.66 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -146.77 66.44 1.17 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--O 1.253 1.275 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 174.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' F3S . . . . . 0.482 ' S4 ' ' NZ ' ' A' ' 12' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' ILE . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.477 ' CG2' HG22 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.27 80.36 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 m 75.91 164.29 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.944 1.297 . . . . 0.0 110.251 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 163.78 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.462 1.505 . . . . 0.0 107.795 168.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -44.95 -65.28 0.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.811 2.045 . . . . 0.0 113.218 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.8 64.13 1.75 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.281 1.033 . . . . 0.0 109.967 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.16 155.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.753 0.821 . . . . 0.0 112.097 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -79.27 -64.49 1.17 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.675 1.19 . . . . 0.0 109.815 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 18' ' ' GLU 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 17' ' ' VAL . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 2' ' ' TYR . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 4' ' ' ILE . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -107.45 15.16 25.15 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -81.47 -33.35 32.04 Favored 'General case' 0 C--N 1.335 -0.045 0 O-C-N 122.047 -0.408 . . . . 0.0 111.591 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 C-N-CA 127.157 2.183 . . . . 0.0 106.861 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.83 -16.04 26.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m 73.66 83.84 0.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.435 1.894 . . . . 0.0 108.684 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -56.96 -66.15 0.5 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -165.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.79 -96.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -155.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.39 156.55 37.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.506 1.146 . . . . 0.0 113.562 -165.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -90.13 67.98 7.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.856 1.262 . . . . 0.0 110.506 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -40.7 -46.91 2.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.859 0.864 . . . . 0.0 111.247 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.88 -4.31 15.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.253 11.6 tppt? -10.36 -108.4 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -130.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 36' ' ' PRO . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD21 ' A' ' 71' ' ' ASN . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.36 -27.2 4.18 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -64.21 -41.81 96.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.049 1.425 . . . . 0.0 107.324 162.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 80.89 -58.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 150.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.83 113.62 11.06 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.716 1.206 . . . . 0.0 109.447 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.85 169.97 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.669 0.788 . . . . 0.0 108.978 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -74.84 36.46 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -159.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p -70.26 -51.64 29.05 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 161.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.44 HD21 HG22 ' A' ' 4' ' ' ILE . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 -125.17 16.14 8.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 132.18 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.234 0.925 . . . . 0.0 110.415 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.363 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 163.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 71' ' ' ASN . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 6' ' ' GLU . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 12.49 59.01 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m 63.97 57.09 1.35 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -60.45 106.97 0.6 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.552 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 85.76 -60.7 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.514 2.725 . . . . 0.0 111.754 165.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.66 -161.73 1.16 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.785 1.234 . . . . 0.0 108.999 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.7 t -143.89 164.81 29.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p -108.34 9.4 27.83 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.12 2.168 . . . . 0.0 110.544 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 4' ' ' ILE . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -112.16 16.25 20.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -111.58 -35.79 5.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.314 1.046 . . . . 0.0 111.131 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -146.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 HD21 ' A' ' 71' ' ' ASN . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.51 -26.81 18.08 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -68.46 -56.14 9.41 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.116 0.958 . . . . 0.0 109.249 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 65.85 -64.34 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.346 1.858 . . . . 0.0 113.794 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -108.38 89.37 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.449 1.1 . . . . 0.0 109.69 -169.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.04 -157.95 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -42.12 -36.56 1.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 128.001 2.52 . . . . 0.0 116.417 -163.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p -68.83 -19.52 64.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.66 1.184 . . . . 0.0 112.174 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 68' ' ' ILE . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.576 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.29 31.88 6.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -154.42 97.85 2.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.423 ' OXT' ' NZ ' ' A' ' 77' ' ' LYS 0.314 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.382 2.673 . . . . 0.0 116.123 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.477 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.23 4.49 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m -49.04 142.41 6.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.646 1.179 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -141.62 94.44 2.68 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.44 -164.25 1.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 156.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.43 -27.17 3.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.916 2.086 . . . . 0.0 109.272 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.2 m -42.77 -47.26 5.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -66.98 -38.14 85.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.477 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 -110.36 12.13 23.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -108.16 -38.97 5.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.302 1.041 . . . . 0.0 110.734 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HZ3' ' C ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 115.897 -2.001 . . . . 0.0 108.224 -146.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.69 -48.0 0.98 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -63.2 131.06 47.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -134.46 26.15 3.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.483 1.513 . . . . 0.0 108.92 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.16 -111.15 0.27 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -154.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.83 162.72 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.342 1.857 . . . . 0.0 106.258 -175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 146.13 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 130.106 3.362 . . . . 0.0 108.837 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -81.23 -49.76 10.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.758 0.423 . . . . 0.0 111.227 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 68' ' ' ILE . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -110.11 44.21 1.26 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -150.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.069 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.426 -1.673 0 C-N-CA 131.673 3.989 . . . . 0.0 104.465 -169.419 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 HD21 ' A' ' 71' ' ' ASN . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.87 -7.46 55.22 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m 54.29 46.05 25.98 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.542 1.171 . . . . 0.0 108.118 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.44 19.14 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -156.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -126.81 -88.12 0.57 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.698 0.799 . . . . 0.0 109.554 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.59 -106.89 0.09 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.649 0.38 . . . . 0.0 110.34 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -165.37 143.13 5.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p -130.0 4.32 4.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.548 1.939 . . . . 0.0 110.783 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.508 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HA ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 4' ' ' ILE . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -119.51 -9.44 9.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -72.14 -40.25 68.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.765 1.626 . . . . 0.0 110.526 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.561 2.344 . . . . 0.0 106.878 169.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.504 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 -32.11 2.53 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -74.91 69.97 1.92 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.818 1.247 . . . . 0.0 109.613 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.64 78.74 2.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.603 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.06 -159.68 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 168.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.63 -4.79 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 111.766 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 m -57.56 -42.29 82.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 112.598 -172.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 19' ' ' VAL . 27.5 p -71.68 -51.94 20.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.089 0.404 . . . . 0.0 111.205 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 16' ' ' CYS . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.504 HD21 HG22 ' A' ' 4' ' ' ILE . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 -121.03 14.47 11.47 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.72 -36.09 3.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.868 0.467 . . . . 0.0 111.295 -170.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.864 -152.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 68' ' ' ILE . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.707 HG22 HD21 ' A' ' 71' ' ' ASN . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 31' ' ' GLN . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.08 4.81 23.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.8 m -69.83 -46.08 66.4 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.155 1.478 . . . . 0.0 110.961 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.13 163.91 31.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -70.92 -174.7 0.98 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.919 1.288 . . . . 0.0 109.247 162.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -21.43 117.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.729 2.412 . . . . 0.0 114.066 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB2' ' S4 ' ' A' ' 78' ' ' F3S . 4.0 m -149.05 -37.41 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.534 0.734 . . . . 0.0 112.41 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p -106.61 23.26 14.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 112.158 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 9' ' ' ILE . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 68' ' ' ILE . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HA ' HD13 ' A' ' 68' ' ' ILE . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.577 ' CD1' HG11 ' A' ' 60' ' ' VAL . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.707 HD21 HG22 ' A' ' 4' ' ' ILE . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -122.13 21.14 10.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -34.86 3.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.212 1.005 . . . . 0.0 111.271 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HB3' ' HZ2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.674 -1.632 . . . . 0.0 107.363 -153.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' F3S . . . . . 0.478 ' S4 ' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.53 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 41' ' ' ASP 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.2 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 3' ' ' VAL . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 68' ' ' ILE . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.452 HD21 HG22 ' A' ' 4' ' ' ILE . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG22 ' A' ' 60' ' ' VAL . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.893 0.378 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' PHE . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 3' ' ' VAL . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.434 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 26' ' ' HIS . 16.1 m-85 . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 60' ' ' VAL . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.629 ' CG2' HG22 ' A' ' 60' ' ' VAL . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 6' ' ' GLU . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 33' ' ' TYR . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 28' ' ' GLY . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.629 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 36' ' ' PRO 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.411 ' CG2' HG22 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.558 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.605 ' HB2' HD12 ' A' ' 25' ' ' ILE . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 20' ' ' CYS . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.407 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-O 121.435 0.636 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.615 HD21 HG22 ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' ILE . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.477 ' CG2' HG22 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 18' ' ' GLU 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 17' ' ' VAL . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 2' ' ' TYR . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 4' ' ' ILE . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.558 0.218 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 . . . . . 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.46 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 36' ' ' PRO . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD21 ' A' ' 71' ' ' ASN . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.44 HD21 HG22 ' A' ' 4' ' ' ILE . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 . . . . . 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 71' ' ' ASN . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 6' ' ' GLU . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 120.983 0.42 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 4' ' ' ILE . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 HD21 ' A' ' 71' ' ' ASN . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 68' ' ' ILE . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.576 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.477 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.477 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.56 0.219 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 68' ' ' ILE . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 . . . . . 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 HD21 ' A' ' 71' ' ' ASN . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.813 0.339 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.508 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HA ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 4' ' ' ILE . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.504 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 19' ' ' VAL . 27.5 p . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 119.853 -0.118 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 16' ' ' CYS . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.504 HD21 HG22 ' A' ' 4' ' ' ILE . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 68' ' ' ILE . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.707 HG22 HD21 ' A' ' 71' ' ' ASN . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 31' ' ' GLN . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 9' ' ' ILE . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 68' ' ' ILE . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HA ' HD13 ' A' ' 68' ' ' ILE . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.577 ' CD1' HG11 ' A' ' 60' ' ' VAL . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.707 HD21 HG22 ' A' ' 4' ' ' ILE . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 . . . . . 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.53 ' H1 ' ' CG ' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 119.054 -0.498 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -99.18 116.52 31.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.671 1.589 . . . . 0.0 108.7 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -130.23 161.93 39.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 121.673 0.749 . . . . 0.0 110.462 -165.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.18 163.18 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.346 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.484 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.3 p -130.34 -98.4 0.34 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 155.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.54 -58.4 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.397 -146.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -50.9 -25.3 15.5 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.9 t -67.88 -24.31 65.22 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.379 0.99 . . . . 0.0 111.917 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 87.7 mt -43.86 117.45 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.389 0 C-N-CA 124.345 1.058 . . . . 0.0 111.352 -175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.61 15.83 13.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.875 1.702 . . . . 0.0 114.327 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -107.12 100.02 9.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.354 1.077 . . . . 0.0 108.866 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 60.93 -156.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.077 1.751 . . . . 0.0 113.283 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -153.63 173.19 16.11 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.84 2.056 . . . . 0.0 106.973 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.16 -168.27 0.16 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.017 1.727 . . . . 0.0 113.254 168.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 p 55.62 38.5 30.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.569 1.948 . . . . 0.0 113.309 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -166.9 -53.98 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.257 1.823 . . . . 0.0 108.652 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -53.55 -43.18 52.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 123.812 0.845 . . . . 0.0 112.719 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -79.37 -19.49 50.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.901 1.28 . . . . 0.0 112.663 -172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -87.41 -23.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.9 0.773 . . . . 0.0 112.842 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.73 122.73 88.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -162.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.55 -12.8 36.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.392 2.728 . . . . 0.0 113.736 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.3 m -121.78 17.49 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.407 0.683 . . . . 0.0 111.328 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.37 23.26 3.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.009 1.324 . . . . 0.0 113.468 168.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.7 p -92.67 15.08 15.22 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.091 -1.006 . . . . 0.0 113.626 -165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 124.72 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -133.4 177.69 7.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.49 1.516 . . . . 0.0 107.471 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -93.21 147.25 23.05 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.534 -0.729 . . . . 0.0 111.832 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.39 -168.59 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 161.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -54.63 -59.53 4.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.464 1.506 . . . . 0.0 111.072 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -103.62 -68.58 0.83 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.217 1.407 . . . . 0.0 109.033 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -88.95 170.92 10.27 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 110.162 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -77.11 163.03 26.99 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.739 169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -125.69 173.66 8.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 127.432 2.293 . . . . 0.0 109.537 170.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -134.86 131.07 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 125.303 1.441 . . . . 0.0 107.407 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -70.49 114.11 23.62 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 120.364 1.438 . . . . 0.0 109.709 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.38 -22.11 9.78 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 121.682 1.588 . . . . 0.0 111.451 -174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -79.38 -30.6 42.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.648 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.33 -47.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.963 0.905 . . . . 0.0 110.577 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 16.1 t -49.14 125.1 10.04 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 0.0 111.697 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.6 pp -89.36 21.24 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 3.9 m-20 54.25 45.95 26.25 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.712 1.605 . . . . 0.0 111.34 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.62 -20.16 36.89 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.876 -175.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.59 -124.42 10.75 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -165.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 62.95 -72.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.502 1.521 . . . . 0.0 111.964 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -46.99 -50.49 19.02 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.775 1.23 . . . . 0.0 109.837 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -29.97 -54.2 0.16 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.699 2.4 . . . . 0.0 113.218 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.98 -39.06 63.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.003 0.521 . . . . 0.0 111.048 -169.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.97 -33.05 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.696 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -61.84 125.37 84.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 118.374 0.534 . . . . 0.0 109.989 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -52.76 118.82 5.12 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.194 1.929 . . . . 0.0 111.096 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.76 20.79 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.291 1.036 . . . . 0.0 111.333 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.5 t 51.11 54.1 11.81 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.208 1.003 . . . . 0.0 110.557 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.09 -34.58 66.13 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.801 -0.562 . . . . 0.0 110.369 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.4 mt -66.5 109.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 160.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -117.78 150.32 39.33 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.427 1.091 . . . . 0.0 110.296 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.19 139.79 58.8 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.197 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.72 -21.58 19.35 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -163.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.59 -14.4 14.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.149 1.379 . . . . 0.0 112.431 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -72.57 -39.84 67.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.7 t -46.33 125.08 7.38 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 124.937 1.295 . . . . 0.0 109.601 171.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.8 149.67 81.96 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.043 1.828 . . . . 0.0 109.797 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -47.39 -46.44 26.1 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.584 0.753 . . . . 0.0 110.626 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -40.29 -50.91 2.78 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.076 1.351 . . . . 0.0 111.881 171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -93.58 -4.82 50.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -58.0 -24.27 57.46 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.924 1.238 . . . . 0.0 110.357 163.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -46.95 -49.99 19.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.747 -0.596 . . . . 0.0 111.51 164.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -64.96 -37.63 88.29 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.619 -0.675 . . . . 0.0 111.118 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -48.22 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -60.23 -33.83 72.82 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.511 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -64.47 -50.44 67.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.246 0.93 . . . . 0.0 112.374 172.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.91 -44.94 78.73 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.412 176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.4 mtt85 -52.3 -59.77 4.01 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.371 170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -43.89 -53.82 5.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.075 0.95 . . . . 0.0 110.298 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.19 -40.32 11.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 112.972 -1.922 . . . . 0.0 112.458 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -114.19 14.09 18.11 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -35.96 4.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.335 0.654 . . . . 0.0 110.623 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.778 -149.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' A' ' 41' ' ' ASP 2.277 . . . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.87 130.81 36.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.664 1.186 . . . . 0.0 108.939 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -135.47 159.35 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 122.369 1.08 . . . . 0.0 110.462 -166.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.452 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -67.05 159.4 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.223 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.5 p -140.2 169.76 17.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 158.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -18.74 -62.98 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 128.272 2.629 . . . . 0.0 114.929 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.18 -19.82 17.49 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.789 2.326 . . . . 0.0 117.381 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 t -66.66 -29.67 69.74 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.59 1.541 . . . . 0.0 111.006 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 87.6 mt -48.89 119.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 123.985 0.914 . . . . 0.0 112.998 -164.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.7 21.98 45.11 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.474 1.035 . . . . 0.0 114.793 172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -70.65 -55.44 8.75 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.1 1.45 . . . . 0.0 110.988 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 26.0 tttm -152.21 156.66 40.18 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.498 1.119 . . . . 0.0 108.588 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -56.1 172.7 0.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.089 1.355 . . . . 0.0 111.488 159.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -8.22 102.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 128.485 2.714 . . . . 0.0 114.664 170.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -144.67 177.75 8.47 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.393 13.3 p 58.5 -50.34 0.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.366 2.666 . . . . 0.0 115.039 -171.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.4 p -32.88 -46.46 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 126.87 2.068 . . . . 0.0 114.046 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.01 -34.42 29.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.658 1.183 . . . . 0.0 112.617 -172.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.22 -15.73 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -162.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.5 t -76.62 127.5 84.17 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 118.544 0.611 . . . . 0.0 111.548 -165.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.75 -43.82 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.774 2.316 . . . . 0.0 111.882 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.47 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -46.02 114.63 0.82 Allowed 'General case' 0 C--N 1.34 0.191 0 CA-C-O 121.863 0.84 . . . . 0.0 111.98 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.6 p -144.28 28.92 1.32 Allowed 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.974 1.71 . . . . 0.0 107.99 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -89.04 113.92 26.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -121.73 170.99 9.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.842 0.857 . . . . 0.0 108.739 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.83 149.85 21.91 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.18 -144.18 7.09 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 164.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -63.58 -64.07 1.0 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.933 1.293 . . . . 0.0 110.64 -170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.54 -63.67 1.14 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.2 pt20 -91.16 -177.95 5.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.388 -169.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -98.44 159.15 15.14 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.017 173.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.58 172.17 12.86 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.04 1.736 . . . . 0.0 108.285 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.0 mt -134.62 149.32 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -90.93 101.48 4.0 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 120.464 1.484 . . . . 0.0 111.032 161.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' HB3' HG22 ' A' ' 3' ' ' VAL . 19.1 Cg_endo -60.59 -22.6 73.03 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.442 1.428 . . . . 0.0 113.574 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.15 -22.09 53.1 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 118.99 0.813 . . . . 0.0 110.114 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.7 t -84.48 -51.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.248 0.619 . . . . 0.0 109.381 170.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.1 t -48.59 126.66 12.09 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.33 0.586 . . . . 0.0 110.508 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.77 29.17 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -168.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 7.8 m-20 47.23 50.97 13.8 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.463 1.029 . . . . 0.0 111.549 -168.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.41 -176.15 4.45 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.052 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.06 -116.67 2.99 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 68.2 -70.42 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.123 1.769 . . . . 0.0 111.956 175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.1 p -51.69 -47.35 63.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.231 1.012 . . . . 0.0 109.824 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -31.04 -51.14 0.16 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.388 2.675 . . . . 0.0 113.549 165.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.92 -41.67 14.73 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.912 0.885 . . . . 0.0 110.854 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.5 m -79.15 -23.55 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.047 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 40.0 t -50.75 116.39 6.98 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -49.67 -36.56 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.42 2.747 . . . . 0.0 114.015 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 t -93.92 -19.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.665 0.786 . . . . 0.0 110.823 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 t 53.4 67.22 1.03 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.899 0.88 . . . . 0.0 109.134 -162.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.82 -22.13 17.11 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.798 2.039 . . . . 0.0 110.778 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.39 108.29 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -123.99 150.37 44.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 0.0 110.753 -175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.66 141.05 48.28 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -49.23 -28.87 5.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.767 1.227 . . . . 0.0 114.15 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.69 -55.5 7.57 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 110.001 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -62.8 -34.08 76.55 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.061 2.144 . . . . 0.0 110.077 -176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 68' ' ' ILE . 4.1 t -48.39 131.73 13.21 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.812 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.52 155.27 69.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.003 1.802 . . . . 0.0 110.712 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -49.73 -38.91 35.54 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.93 0.892 . . . . 0.0 111.313 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -50.8 -46.28 59.7 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.351 0.596 . . . . 0.0 111.18 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.254 44.7 m0 -98.29 -0.03 44.71 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.508 1.123 . . . . 0.0 113.238 -169.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -46.11 -36.08 5.53 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.32 -0.863 . . . . 0.0 110.08 154.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.1 m -51.04 -57.28 9.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.911 0.884 . . . . 0.0 111.879 170.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -60.85 -37.43 82.07 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 121.714 -0.616 . . . . 0.0 110.56 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -64.52 -47.19 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.619 -178.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.82 -37.86 69.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 118.589 -0.72 . . . . 0.0 110.428 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -64.12 -51.39 64.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.268 0.94 . . . . 0.0 112.489 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.452 HD21 HG22 ' A' ' 4' ' ' ILE . 3.9 m-80 -52.96 -42.58 65.62 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.296 -0.878 . . . . 0.0 110.711 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -58.47 -59.57 5.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.014 171.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -42.17 -53.29 4.09 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.967 1.707 . . . . 0.0 110.693 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -45.5 -38.24 6.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.789 2.036 . . . . 0.0 112.594 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -121.06 22.34 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 122.688 0.395 . . . . 0.0 111.836 -171.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.23 -44.13 2.5 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.822 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.239 0 C-N-CA 126.423 1.889 . . . . 0.0 107.948 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.283 . . . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -97.71 125.21 42.39 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.724 1.209 . . . . 0.0 108.506 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.7 t -136.29 158.91 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 122.417 1.103 . . . . 0.0 111.228 -163.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tp -64.64 163.02 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.314 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' CG2' HG22 ' A' ' 60' ' ' VAL . 11.9 p -122.8 -92.57 0.53 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 163.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.36 -65.55 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.269 -151.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.13 -25.65 38.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.187 1.925 . . . . 0.0 114.147 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.8 t -50.16 -39.36 43.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.533 1.533 . . . . 0.0 112.92 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -49.36 137.15 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.684 1.194 . . . . 0.0 112.101 -170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.27 -25.18 8.21 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.477 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 35.4 m -65.68 -37.6 86.95 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.762 1.781 . . . . 0.0 111.418 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt 58.95 -101.59 0.13 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.087 1.355 . . . . 0.0 112.082 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -94.74 68.55 3.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.802 0.441 . . . . 0.0 110.172 -158.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -107.24 164.32 12.27 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 110.053 170.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.2 m -66.35 -6.69 15.07 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 116.38 1.992 . . . . 0.0 116.38 -158.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.4 p -49.03 -39.65 27.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.89 1.223 . . . . 0.0 110.739 173.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.9 -38.61 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.018 0.927 . . . . 0.0 113.174 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.2 -38.96 50.4 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.703 0.683 . . . . 0.0 110.844 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.17 -24.31 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -157.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.0 t -69.03 119.35 69.29 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.06 -28.91 7.98 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.672 3.581 . . . . 0.0 115.732 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.99 18.83 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.951 0.9 . . . . 0.0 111.205 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 56.81 16.19 2.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.255 1.422 . . . . 0.0 113.754 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.9 p -87.24 27.4 1.06 Allowed 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.37 -1.456 . . . . 0.0 113.834 -160.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.15 120.41 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 75' ' ' PHE . 59.4 m-70 -134.14 170.12 16.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.785 1.234 . . . . 0.0 108.516 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.74 154.24 23.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.75 1.159 . . . . 0.0 113.024 -172.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.3 -162.91 18.84 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 125.839 1.685 . . . . 0.0 109.602 159.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.51 -67.11 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.929 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.46 -71.64 0.59 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -90.77 151.25 21.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.237 -159.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -69.35 149.29 48.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.39 0.614 . . . . 0.0 112.118 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -117.78 176.78 5.03 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 128.178 2.591 . . . . 0.0 109.47 173.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.67 152.87 27.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -91.81 108.4 29.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 119.02 0.827 . . . . 0.0 109.986 164.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HB3' HG22 ' A' ' 3' ' ' VAL . 38.3 Cg_endo -84.48 -4.13 10.08 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.284 1.989 . . . . 0.0 114.235 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -78.44 -38.01 42.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.9 t -78.18 -48.97 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.771 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.413 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 16.2 t -53.18 127.06 22.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.114 0.483 . . . . 0.0 109.789 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.72 28.69 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -167.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 46.92 55.72 7.58 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.295 0.952 . . . . 0.0 111.525 -166.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.97 -167.3 1.61 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.863 171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.13 -127.85 3.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 72.82 -61.97 0.48 Allowed 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.015 2.526 . . . . 0.0 110.518 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -57.43 -48.23 79.69 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.4 0.68 . . . . 0.0 110.286 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -41.96 86.11 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.567 -0.708 . . . . 0.0 112.192 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.88 -46.21 88.91 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.776 0.43 . . . . 0.0 110.641 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.42 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 122.24 -0.288 . . . . 0.0 111.615 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.8 t -60.96 127.84 88.26 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.825 0.85 . . . . 0.0 110.793 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.4 117.95 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.611 2.207 . . . . 0.0 111.874 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 59.63 21.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.266 1.026 . . . . 0.0 111.393 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.3 m 48.6 54.71 10.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.118 0.967 . . . . 0.0 111.324 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.13 -30.88 64.78 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.956 -0.465 . . . . 0.0 110.529 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.68 108.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 161.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -121.42 152.66 38.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.939 0.896 . . . . 0.0 110.184 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -67.96 138.7 56.14 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -50.2 -29.39 9.24 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -92.69 -32.19 14.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.11 0.414 . . . . 0.0 112.004 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -66.44 -37.16 84.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.036 1.334 . . . . 0.0 108.878 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.4 t -44.99 131.1 5.38 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 166.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.27 150.29 87.54 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.506 1.471 . . . . 0.0 109.697 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -42.29 -46.0 4.39 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 126.981 2.112 . . . . 0.0 111.392 175.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -42.88 -49.06 5.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.146 1.378 . . . . 0.0 111.568 172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -98.5 -3.31 36.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.225 1.41 . . . . 0.0 113.638 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -56.03 -26.64 49.82 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.661 -1.274 . . . . 0.0 110.504 163.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.9 m -47.88 -54.35 12.89 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.587 1.155 . . . . 0.0 111.988 163.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -62.97 -35.96 81.92 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 121.656 -0.652 . . . . 0.0 111.017 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.434 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.39 -49.53 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -59.49 -37.79 79.16 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.745 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -57.2 -55.76 30.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.966 1.257 . . . . 0.0 112.193 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.9 -49.3 50.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.298 0.639 . . . . 0.0 109.382 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -56.59 -42.6 78.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 122.339 -0.226 . . . . 0.0 111.139 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -50.1 71.22 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.134 0.973 . . . . 0.0 109.583 -176.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -46.4 -40.35 11.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.66 1.184 . . . . 0.0 111.565 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 26' ' ' HIS . 16.1 m-85 -121.22 32.52 5.89 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.12 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -67.68 175.0 3.14 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 122.896 1.331 . . . . 0.0 110.286 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 N--CA 1.431 -1.413 0 C-N-CA 128.393 2.677 . . . . 0.0 104.987 -154.628 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.288 . . . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.607 -0.235 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -85.02 136.65 33.49 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -140.75 163.74 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 122.238 1.018 . . . . 0.0 110.999 -167.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 tp -72.03 160.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.06 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.0 p -140.04 169.71 17.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.46 0.647 . . . . 0.0 109.867 159.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -18.74 -64.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 128.597 2.759 . . . . 0.0 115.347 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.61 -23.97 27.6 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.543 2.162 . . . . 0.0 116.458 -172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.3 t -68.35 -27.34 66.17 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.097 1.317 . . . . 0.0 111.207 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.7 mt -47.13 127.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 112.076 -170.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.95 -33.81 6.22 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.154 1.835 . . . . 0.0 110.417 -173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -82.65 117.46 22.61 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.095 -0.65 . . . . 0.0 109.977 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -108.31 167.12 10.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 155.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 49.74 61.58 3.09 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.606 1.562 . . . . 0.0 112.931 161.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.55 153.3 49.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.0 m -76.53 56.72 1.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -167.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.4 p -87.56 -21.37 25.45 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 150.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.45 172.83 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 149.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 75.13 -43.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 130.079 3.352 . . . . 0.0 111.325 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -76.91 -30.22 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.907 0.883 . . . . 0.0 110.978 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.3 t -74.59 123.51 89.12 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.035 0.534 . . . . 0.0 111.0 -171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -40.94 -34.16 1.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 125.177 3.918 . . . . 0.0 115.804 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.91 7.55 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.125 0.97 . . . . 0.0 111.421 -173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 32.19 55.97 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.088 1.755 . . . . 0.0 112.967 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 p -103.35 40.66 1.37 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.427 0.691 . . . . 0.0 110.295 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.85 112.58 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 168.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.36 -170.24 2.14 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.697 1.199 . . . . 0.0 108.664 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.77 126.76 52.17 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 124.73 1.212 . . . . 0.0 112.787 -167.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.26 -172.63 43.29 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 163.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.15 -75.71 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.881 1.273 . . . . 0.0 109.451 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -77.2 -59.03 2.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.049 0.94 . . . . 0.0 108.743 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.38 -163.29 1.02 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.136 0.974 . . . . 0.0 111.415 -169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -93.95 163.71 13.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.367 1.067 . . . . 0.0 110.348 162.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -124.45 172.45 9.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.586 1.155 . . . . 0.0 109.768 161.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.8 mt -118.38 147.13 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.85 88.2 0.31 Allowed Pre-proline 0 N--CA 1.444 -0.758 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -77.38 -2.28 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 CA-C-N 121.429 1.546 . . . . 0.0 113.011 -164.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -19.14 24.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 110.143 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.6 t -92.43 -49.91 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 108.989 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 28.9 t -50.59 137.6 19.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -107.41 34.53 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.752 1.221 . . . . 0.0 110.142 -168.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 45.01 50.34 9.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.621 0.725 . . . . 0.0 112.308 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.25 -174.57 4.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.485 174.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -138.66 131.61 5.41 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 176.49 -56.57 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 127.759 2.424 . . . . 0.0 108.096 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 24.7 p -56.37 -42.82 78.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.459 1.503 . . . . 0.0 112.091 -173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -55.83 -33.52 64.55 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.611 -0.681 . . . . 0.0 112.276 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 122.153 -0.342 . . . . 0.0 110.712 -174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.0 m -87.87 -34.58 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-O 119.319 -0.372 . . . . 0.0 111.121 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.0 t -58.62 127.31 81.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 118.27 0.487 . . . . 0.0 110.596 -177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.81 120.93 6.56 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.491 2.128 . . . . 0.0 111.451 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t 60.06 19.14 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.15 0.98 . . . . 0.0 111.497 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t 48.05 52.79 12.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.641 0.776 . . . . 0.0 110.362 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -30.92 58.41 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.279 0.49 . . . . 0.0 110.448 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.28 114.45 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 164.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -130.17 154.98 46.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.604 1.162 . . . . 0.0 110.524 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -76.67 142.68 40.48 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 122.009 -0.432 . . . . 0.0 109.978 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 72' ' ' ARG . 9.8 pt-20 -52.04 -28.34 16.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -173.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -73.13 -54.62 8.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.684 0.793 . . . . 0.0 110.275 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -63.09 -34.86 78.49 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 127.36 2.264 . . . . 0.0 109.977 -175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -47.98 127.85 11.74 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.411 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -60.06 147.82 91.62 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.655 1.57 . . . . 0.0 110.038 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -45.39 -44.68 12.13 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 127.378 2.271 . . . . 0.0 111.953 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -45.15 -49.2 12.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 111.098 171.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -96.73 -5.44 38.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.419 1.488 . . . . 0.0 112.999 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -50.81 -29.82 12.64 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.589 -0.695 . . . . 0.0 109.76 160.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -51.99 -57.13 10.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.494 1.118 . . . . 0.0 112.687 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -61.04 -39.32 89.33 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 121.387 -0.821 . . . . 0.0 110.349 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.489 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -61.06 -50.41 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.29 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -38.02 66.69 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.254 172.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -59.63 -57.57 12.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.742 1.155 . . . . 0.0 112.182 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -52.94 -41.66 64.71 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -60.33 -46.8 88.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.779 -0.576 . . . . 0.0 110.91 174.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.72 -47.76 79.25 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.134 1.373 . . . . 0.0 109.61 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -45.6 -36.91 5.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.144 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -129.06 38.7 3.89 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.765 0.826 . . . . 0.0 111.956 -175.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -90.63 159.3 16.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 122.386 1.089 . . . . 0.0 111.217 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.461 0 C-N-CA 128.806 2.843 . . . . 0.0 104.293 -149.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.309 . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.27 123.27 43.42 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.5 t -133.46 161.81 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.92 0.867 . . . . 0.0 110.996 -165.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.0 tp -63.68 165.22 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.063 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 60' ' ' VAL . 17.5 p -124.15 -94.08 0.49 Allowed 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 154.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 -59.8 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.237 -148.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -47.96 -22.31 3.33 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.721 2.28 . . . . 0.0 116.535 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.8 t -57.0 -42.32 80.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.726 0.811 . . . . 0.0 111.59 173.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mt -36.35 125.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.314 0 C-N-CA 126.235 1.814 . . . . 0.0 113.968 -155.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.82 -48.31 2.64 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.199 0.904 . . . . 0.0 112.442 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 67.08 0.33 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.339 1.856 . . . . 0.0 111.879 -174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -72.11 76.93 0.95 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.154 -0.966 . . . . 0.0 108.847 169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.77 -74.56 0.27 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.437 0.695 . . . . 0.0 110.249 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.74 177.02 5.26 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 122.745 1.259 . . . . 0.0 113.569 -161.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 75.1 m -73.66 52.58 0.4 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.808 2.043 . . . . 0.0 113.808 -172.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p -82.63 100.72 10.35 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 153.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p 167.52 -54.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 128.802 2.841 . . . . 0.0 109.096 167.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -61.53 -33.5 73.93 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.172 0.989 . . . . 0.0 111.475 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.51 -26.11 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -162.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.6 t -72.18 123.37 89.39 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 118.876 0.762 . . . . 0.0 112.936 -159.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.09 -31.66 65.93 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.964 3.11 . . . . 0.0 114.922 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 m -121.14 58.73 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.296 1.038 . . . . 0.0 109.257 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 14.02 68.76 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.966 2.906 . . . . 0.0 114.179 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -143.88 -178.58 5.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.2 mt 89.86 111.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -151.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -133.4 176.13 8.8 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.796 2.038 . . . . 0.0 107.748 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -99.46 152.41 20.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.7 0.286 . . . . 0.0 110.597 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.03 -160.77 17.02 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.619 1.581 . . . . 0.0 110.019 170.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -58.88 -62.28 1.99 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.202 1.401 . . . . 0.0 110.314 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -103.18 -64.73 1.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.615 1.566 . . . . 0.0 108.417 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -85.15 -173.98 5.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.474 -170.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -103.67 162.95 12.65 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 123.108 0.563 . . . . 0.0 110.259 174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -133.21 176.9 8.1 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 126.18 1.792 . . . . 0.0 109.565 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -138.02 137.77 44.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -76.7 109.94 10.23 Favored Pre-proline 0 N--CA 1.449 -0.506 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 167.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -76.0 -12.9 19.55 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.032 1.155 . . . . 0.0 113.054 -175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.3 -27.51 15.45 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.28 -51.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 123.006 0.523 . . . . 0.0 109.611 160.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 36.6 t -54.81 143.52 25.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.911 0.386 . . . . 0.0 110.405 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.09 31.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.006 0.923 . . . . 0.0 112.188 -173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 51.65 42.92 30.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.534 0.734 . . . . 0.0 112.423 -175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -26.61 31.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.06 -142.81 30.04 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.009 0.814 . . . . 0.0 111.675 -168.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 74.78 -57.71 0.6 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.043 2.537 . . . . 0.0 110.603 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.6 p -60.68 -34.39 74.25 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.158 0.983 . . . . 0.0 111.366 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -45.55 86.49 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 119.776 1.171 . . . . 0.0 110.409 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.35 93.5 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.726 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.53 -37.86 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.025 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.0 114.99 11.99 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 118.347 0.522 . . . . 0.0 110.535 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -58.83 -35.09 99.18 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.612 2.208 . . . . 0.0 112.288 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.4 t -90.29 -10.89 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.676 0.79 . . . . 0.0 110.256 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 86.6 p 51.39 36.64 17.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.357 1.463 . . . . 0.0 112.228 -167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.34 -32.54 68.62 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.639 -0.663 . . . . 0.0 110.539 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 94.4 mt -68.35 109.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 171.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -128.25 154.71 45.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.921 1.288 . . . . 0.0 110.572 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -70.44 145.09 51.23 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.005 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -42.68 -44.7 4.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.699 1.6 . . . . 0.0 113.567 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -75.08 -47.12 30.39 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.377 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -57.65 -36.62 72.11 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.083 1.753 . . . . 0.0 108.977 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.1 t -56.37 123.8 57.75 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.81 151.85 83.29 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.22 1.947 . . . . 0.0 109.659 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -45.97 -44.79 15.25 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.32 2.248 . . . . 0.0 111.444 178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -41.24 -50.55 3.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.475 1.11 . . . . 0.0 110.926 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 43.4 m0 -100.62 -4.63 28.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.77 1.628 . . . . 0.0 113.374 -172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -52.33 -30.75 29.96 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.56 1.073 . . . . 0.0 109.69 162.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -46.96 -52.37 14.81 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.997 1.319 . . . . 0.0 112.366 165.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -64.33 -34.86 79.11 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 111.133 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.72 -47.65 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -56.7 -42.89 79.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.101 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.95 -53.02 62.77 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.488 1.04 . . . . 0.0 112.69 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -51.91 -47.46 64.61 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.646 0.778 . . . . 0.0 109.674 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 mtt85 -56.07 -51.78 66.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.486 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.42 -42.98 83.42 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.618 0.767 . . . . 0.0 109.765 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -39.51 19.56 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.175 0.99 . . . . 0.0 112.983 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.87 31.26 6.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.358 0.663 . . . . 0.0 110.839 -174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -141.72 -160.0 1.03 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.146 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 148.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.307 . . . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 118.374 -0.822 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -91.26 138.35 31.66 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.95 0.796 . . . . 0.0 109.467 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -137.52 161.75 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-O 121.34 0.59 . . . . 0.0 110.057 -165.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.2 tp -73.25 162.34 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 122.168 -0.333 . . . . 0.0 111.084 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.629 ' CG2' HG22 ' A' ' 60' ' ' VAL . 61.0 p -135.54 163.54 29.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.739 0.78 . . . . 0.0 109.884 153.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.3 tp10 -10.79 -67.15 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 128.62 2.768 . . . . 0.0 115.872 163.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -54.49 -10.82 2.55 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 118.178 2.338 . . . . 0.0 118.178 -169.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.9 t -69.58 -30.4 68.16 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.651 1.568 . . . . 0.0 112.712 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 6' ' ' GLU . 1.4 mm -43.49 120.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.824 1.25 . . . . 0.0 110.731 -166.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.87 25.03 3.41 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.728 2.109 . . . . 0.0 115.068 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -103.1 127.44 50.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.813 1.307 . . . . 0.0 110.1 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 pttp 58.84 -155.11 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.554 1.942 . . . . 0.0 114.589 168.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -89.22 -163.59 1.02 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.621 2.369 . . . . 0.0 109.292 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.82 -81.09 0.12 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.007 0.923 . . . . 0.0 111.174 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 74.3 -50.9 0.68 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.861 1.264 . . . . 0.0 113.271 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 24.4 p -82.43 -28.68 31.19 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.11 -45.29 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 120.556 -1.34 . . . . 0.0 110.293 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -51.1 -29.09 12.2 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.592 1.957 . . . . 0.0 112.344 -173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.6 -20.16 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.501 0.72 . . . . 0.0 112.594 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.7 t -73.94 118.33 68.5 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 118.951 0.796 . . . . 0.0 112.245 -162.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.78 -35.56 30.96 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.699 2.932 . . . . 0.0 114.185 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.2 m -113.32 24.77 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.901 0.881 . . . . 0.0 110.954 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.05 -15.88 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 167.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.7 t -83.99 57.23 4.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.696 1.134 . . . . 0.0 113.259 -156.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.33 126.43 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 161.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -132.6 174.02 10.72 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.69 0.796 . . . . 0.0 109.657 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.97 144.03 27.93 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 122.685 0.394 . . . . 0.0 110.444 -176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 33' ' ' TYR . . . -100.3 -153.67 27.1 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 165.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -54.67 -62.66 1.51 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.393 1.477 . . . . 0.0 110.131 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.18 -67.35 1.0 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.506 1.922 . . . . 0.0 107.716 170.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.85 141.32 57.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.447 1.499 . . . . 0.0 111.345 -174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -82.23 151.66 26.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 28' ' ' GLY . 19.7 m-85 -124.28 172.0 9.44 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.465 1.106 . . . . 0.0 110.233 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.7 mt -127.69 155.1 38.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -94.58 105.92 21.13 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 118.752 0.705 . . . . 0.0 109.905 162.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -73.24 -7.98 21.3 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.823 1.682 . . . . 0.0 113.86 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -79.7 -43.34 22.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.0 t -71.23 -49.05 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.053 0.541 . . . . 0.0 109.935 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.6 t -52.98 123.66 12.16 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.607 0.718 . . . . 0.0 110.572 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.72 28.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 42.79 63.07 1.56 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.828 0.74 . . . . 0.0 112.675 -166.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 -27.21 16.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.21 -24.53 4.71 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.331 -0.856 . . . . 0.0 114.617 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.44 -52.66 27.42 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.943 1.371 . . . . 0.0 112.586 -172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.6 p -61.59 -36.46 80.73 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.263 0.625 . . . . 0.0 111.897 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -46.98 54.93 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.443 0.697 . . . . 0.0 109.884 172.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.35 -41.84 80.09 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.33 -37.57 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -172.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -57.78 113.1 5.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.85 -30.49 90.21 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.387 2.058 . . . . 0.0 112.361 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -91.79 -11.29 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.873 0.869 . . . . 0.0 110.436 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.7 p 49.72 41.37 21.9 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 125.382 1.473 . . . . 0.0 111.882 -165.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.41 72.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.817 -0.552 . . . . 0.0 110.077 167.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.6 mt -68.85 125.8 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -143.79 151.02 39.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.812 1.645 . . . . 0.0 109.26 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -64.95 148.89 50.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.924 -0.485 . . . . 0.0 110.041 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.94 -18.39 33.18 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -87.52 -40.48 14.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.977 1.711 . . . . 0.0 110.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -63.92 -39.85 95.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.38 1.072 . . . . 0.0 108.925 172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.629 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -53.87 132.17 57.58 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 124.123 0.969 . . . . 0.0 111.516 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.17 149.17 85.69 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.47 2.114 . . . . 0.0 109.258 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -45.84 -44.83 14.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.507 0.723 . . . . 0.0 110.447 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -40.99 -47.92 3.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.341 1.457 . . . . 0.0 111.956 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -100.73 2.72 41.62 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.625 1.17 . . . . 0.0 113.051 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -60.26 -21.1 61.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.919 -1.113 . . . . 0.0 110.785 163.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.7 p -49.29 -59.69 3.47 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.913 0.885 . . . . 0.0 110.827 165.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -57.45 -38.12 73.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -61.84 -51.74 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -54.61 -41.51 70.07 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.572 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -55.66 -54.63 41.79 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 120.087 1.312 . . . . 0.0 112.624 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.25 0.62 . . . . 0.0 109.65 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -54.66 -46.38 74.01 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.24 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -40.15 71.25 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.159 0.983 . . . . 0.0 109.842 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -49.16 -42.84 40.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.518 0.727 . . . . 0.0 111.771 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -121.81 30.0 6.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.784 -0.627 . . . . 0.0 111.873 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -82.1 165.25 20.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.751 1.263 . . . . 0.0 111.704 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.446 0 C-N-CA 129.059 2.943 . . . . 0.0 104.344 -150.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 36' ' ' PRO 0.324 . . . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -88.44 123.84 33.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.273 2.229 . . . . 0.0 106.302 152.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.49 159.31 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.499 1.12 . . . . 0.0 109.567 -166.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 tp -61.51 160.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.58 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.411 ' CG2' HG22 ' A' ' 60' ' ' VAL . 73.6 p -140.14 166.44 24.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.442 0.639 . . . . 0.0 110.029 155.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -16.15 -59.87 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.814 2.846 . . . . 0.0 116.101 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -51.07 -22.61 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.305 2.003 . . . . 0.0 116.381 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.8 t -65.81 -28.8 69.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.384 1.447 . . . . 0.0 111.81 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -54.72 122.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 120.81 -1.181 . . . . 0.0 110.077 -167.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.31 4.11 88.86 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.594 -1.114 . . . . 0.0 114.13 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.7 p -71.71 -62.41 1.43 Allowed 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.829 1.815 . . . . 0.0 108.59 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.9 tptt 58.97 47.61 11.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.61 1.564 . . . . 0.0 110.146 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.54 -178.61 6.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.59 -9.87 13.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.779 1.632 . . . . 0.0 111.317 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 m -54.26 -52.17 62.21 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 p -73.09 -46.96 48.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 p -52.4 -45.01 44.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -166.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.04 -29.29 67.4 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.89 -16.09 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -156.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.9 t -72.33 118.87 71.24 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 118.875 0.761 . . . . 0.0 112.936 -164.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -50.65 -27.07 18.6 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.915 3.076 . . . . 0.0 114.803 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 m -115.98 23.77 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 111.359 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 70.35 -33.27 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.503 1.921 . . . . 0.0 116.008 163.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.05 49.97 1.16 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.031 1.332 . . . . 0.0 114.383 -150.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.69 129.58 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 158.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -134.93 161.69 34.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -79.75 160.95 26.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.061 -1.055 . . . . 0.0 112.478 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.99 -177.66 20.04 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 164.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -47.36 -61.66 1.8 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.334 1.454 . . . . 0.0 110.585 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -87.96 -61.08 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.207 167.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -92.01 -143.31 0.2 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.66 1.184 . . . . 0.0 112.963 -151.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -124.71 163.5 21.93 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.532 1.133 . . . . 0.0 110.273 163.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.45 174.65 10.38 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 128.143 2.577 . . . . 0.0 108.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -132.27 140.27 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -71.61 113.57 20.93 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 120.252 1.387 . . . . 0.0 108.469 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 1' ' ' ALA . 86.1 Cg_endo -76.68 -30.7 4.67 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 N-CA-C 110.244 -0.714 . . . . 0.0 110.244 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -74.94 -26.49 59.65 Favored 'General case' 0 N--CA 1.434 -1.269 0 O-C-N 121.564 -0.71 . . . . 0.0 109.144 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -73.05 -44.83 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 110.709 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -57.45 103.3 0.12 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -171.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -68.4 20.58 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.775 2.03 . . . . 0.0 115.965 -173.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 52.88 47.16 25.28 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.611 1.164 . . . . 0.0 110.695 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.84 174.17 11.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.851 168.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.45 132.56 7.57 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 168.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 175.92 -61.8 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.407 2.283 . . . . 0.0 108.123 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.4 p -58.6 -44.73 89.97 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.118 0.967 . . . . 0.0 111.779 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -34.51 78.25 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.386 -0.821 . . . . 0.0 111.052 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.35 99.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.128 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.18 -34.42 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.349 -0.358 . . . . 0.0 111.737 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.2 t -56.24 126.77 69.12 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.378 0.535 . . . . 0.0 110.033 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.67 115.38 2.56 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.283 1.988 . . . . 0.0 110.897 -174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t 61.58 23.55 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.216 1.406 . . . . 0.0 111.35 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.9 m 49.42 58.18 5.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.54 1.136 . . . . 0.0 111.158 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.8 -32.02 63.14 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.326 0.584 . . . . 0.0 109.98 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.99 111.05 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 164.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -124.32 154.82 39.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.305 1.442 . . . . 0.0 110.733 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -75.22 142.78 43.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.548 -0.72 . . . . 0.0 110.194 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -42.54 -44.69 4.24 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.748 1.219 . . . . 0.0 113.841 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.25 -54.46 32.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -174.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -63.0 -34.61 77.92 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 127.871 2.468 . . . . 0.0 110.035 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -52.64 124.12 33.05 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -61.66 149.23 90.74 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.665 1.577 . . . . 0.0 109.49 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -46.35 -43.8 16.35 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 126.769 2.028 . . . . 0.0 111.532 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -43.68 -48.5 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.834 0.853 . . . . 0.0 111.483 170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 44.6 m0 -98.86 -4.7 32.46 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 125.864 1.666 . . . . 0.0 113.706 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -52.38 -29.15 22.58 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.043 . . . . 0.0 109.689 159.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 m -52.55 -50.75 62.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.478 1.111 . . . . 0.0 112.514 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -63.28 -38.98 93.27 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 121.356 -0.84 . . . . 0.0 110.357 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.41 -48.27 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -55.51 -41.62 73.34 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.787 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -58.89 -52.09 67.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.424 1.011 . . . . 0.0 112.121 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -52.67 -46.62 67.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.743 0.817 . . . . 0.0 109.415 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.05 -53.92 46.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.22 -45.11 80.06 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.559 0.744 . . . . 0.0 110.863 -172.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -45.1 -43.4 9.63 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.192 -1.367 . . . . 0.0 111.262 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -109.6 15.35 22.94 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.604 0.762 . . . . 0.0 112.942 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -114.94 -55.22 2.5 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 124.059 0.944 . . . . 0.0 110.951 -173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.833 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.558 ' H2 ' ' CG ' ' A' ' 41' ' ' ASP 2.28 . . . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 118.769 -0.634 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -90.52 140.1 30.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.608 0.64 . . . . 0.0 109.41 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -141.76 159.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-O 121.631 0.729 . . . . 0.0 110.972 -169.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 5.1 tp -69.93 165.4 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 60' ' ' VAL . 20.7 p -124.98 -99.45 0.41 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 154.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.88 -62.61 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 118.104 -0.95 . . . . 0.0 110.411 -145.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -49.89 -22.69 7.69 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.247 1.965 . . . . 0.0 115.748 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.9 t -51.83 -46.79 64.45 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 112.463 172.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -34.72 117.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.38 1.472 . . . . 0.0 113.514 -147.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.35 -24.78 8.99 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 123.693 0.663 . . . . 0.0 113.891 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -82.62 58.84 4.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.968 1.384 . . . . 0.0 111.896 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -33.32 39.72 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.005 0.522 . . . . 0.0 111.709 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -39.74 -41.05 1.04 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 127.901 2.48 . . . . 0.0 112.784 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.26 67.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.867 0.467 . . . . 0.0 112.186 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.1 m 70.71 64.74 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.065 1.346 . . . . 0.0 113.743 164.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 p -78.11 -49.1 14.56 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.594 160.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.1 m -42.72 -40.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -168.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -64.94 -27.08 68.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.495 1.118 . . . . 0.0 113.335 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.54 -21.69 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 -156.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.605 ' HB2' HD12 ' A' ' 25' ' ' ILE . 38.9 t -64.14 120.05 61.01 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -158.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -42.07 -34.53 2.77 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 125.047 3.831 . . . . 0.0 115.124 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.01 32.93 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.735 0.814 . . . . 0.0 110.443 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 66.89 -17.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 163.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.6 p -75.54 -10.07 59.13 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -159.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 20' ' ' CYS . 38.7 mt -68.44 95.78 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -113.41 179.28 4.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.368 1.067 . . . . 0.0 110.245 -175.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.05 138.31 41.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.993 0.517 . . . . 0.0 110.522 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.98 -136.04 8.56 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -65.06 -64.39 0.88 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.204 1.002 . . . . 0.0 110.564 -173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -115.03 -61.36 1.76 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.984 1.714 . . . . 0.0 108.496 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -79.03 -179.37 6.63 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.093 0.949 . . . . 0.0 111.5 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -112.07 152.95 27.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.705 1.202 . . . . 0.0 108.344 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -132.37 169.67 16.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 mt -126.38 163.84 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -112.83 104.35 55.87 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 160.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.12 -13.23 39.0 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.178 1.919 . . . . 0.0 112.686 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -69.67 -37.17 76.57 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -83.68 -49.05 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.436 1.094 . . . . 0.0 110.522 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.5 t -53.76 141.39 26.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.051 0.453 . . . . 0.0 110.383 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.61 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.28 39.67 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.875 1.27 . . . . 0.0 110.646 -175.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 18.4 m-20 44.86 37.59 2.42 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -23.99 61.36 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -172.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.49 -144.58 37.46 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.933 1.254 . . . . 0.0 111.516 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.12 -58.5 0.53 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.701 2.4 . . . . 0.0 110.286 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 31.4 p -56.74 -44.51 81.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.134 0.974 . . . . 0.0 110.62 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -39.33 90.58 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.137 -0.977 . . . . 0.0 111.74 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.46 -43.37 93.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.661 0.385 . . . . 0.0 110.546 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.26 -39.85 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.71 0.404 . . . . 0.0 110.731 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.3 126.87 85.35 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.255 0.622 . . . . 0.0 111.04 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.89 119.12 6.18 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.427 2.085 . . . . 0.0 111.21 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 60.39 20.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 124.795 1.238 . . . . 0.0 110.975 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m 49.07 59.44 4.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.457 1.103 . . . . 0.0 111.778 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.27 65.57 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.767 -0.583 . . . . 0.0 110.021 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.4 mt -65.6 110.91 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 159.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.6 153.98 45.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.371 1.468 . . . . 0.0 109.15 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -71.59 147.68 47.36 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -59.69 -21.61 60.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -163.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.17 -14.88 15.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.156 1.782 . . . . 0.0 110.548 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -70.11 -45.91 65.94 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 164.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.6 t -47.39 130.89 10.15 Favored Pre-proline 0 N--CA 1.448 -0.573 0 C-N-CA 125.688 1.595 . . . . 0.0 110.114 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.41 150.59 84.3 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.935 1.757 . . . . 0.0 109.26 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -46.19 -45.29 16.73 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.022 0.929 . . . . 0.0 110.33 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -38.57 -49.73 1.54 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.792 1.637 . . . . 0.0 111.846 172.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 36.8 m0 -100.6 0.44 39.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.075 0.95 . . . . 0.0 112.856 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -59.65 -20.79 58.48 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.346 1.43 . . . . 0.0 110.496 163.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 m -47.08 -53.42 12.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 111.42 162.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -64.0 -35.0 79.26 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.708 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.407 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.8 -48.54 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 119.22 0.918 . . . . 0.0 108.822 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -54.78 -37.43 66.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.813 171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -64.22 -52.72 57.42 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.459 1.027 . . . . 0.0 113.162 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 2.7 m-80 -54.32 -41.09 68.61 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 120.962 -1.086 . . . . 0.0 110.919 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -57.7 -62.36 1.85 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 168.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -41.64 -52.65 3.76 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.26 1.824 . . . . 0.0 111.526 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -44.62 -35.25 2.5 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.032 2.133 . . . . 0.0 112.665 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 86.7 m-85 -128.02 38.44 4.01 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.407 1.083 . . . . 0.0 110.77 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.8 -43.36 0.82 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.459 0.572 . . . . 0.0 111.3 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.202 0 C-N-CA 126.116 1.766 . . . . 0.0 107.795 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -88.92 135.95 33.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.037 0.935 . . . . 0.0 108.837 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.3 t -135.91 155.5 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 121.951 0.882 . . . . 0.0 109.915 -166.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.615 HG22 HD21 ' A' ' 71' ' ' ASN . 2.0 tp -66.36 159.88 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.659 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -142.41 169.1 18.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 161.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -18.64 -66.09 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 128.088 2.555 . . . . 0.0 115.163 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.13 -24.84 21.23 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.184 2.589 . . . . 0.0 116.303 -172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.0 t -66.54 -37.0 84.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.984 1.266 . . . . 0.0 110.888 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.49 122.5 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.385 0 C-N-CA 123.922 0.889 . . . . 0.0 110.484 -172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.06 -49.44 0.85 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -61.63 157.4 17.62 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.924 1.362 . . . . 0.0 112.252 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -143.23 -49.47 0.32 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.297 1.839 . . . . 0.0 108.102 158.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -18.89 -74.03 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.632 3.173 . . . . 0.0 113.894 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -40.59 -47.3 2.7 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.243 1.417 . . . . 0.0 113.524 -174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.5 m 57.7 74.08 0.44 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 169.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.0 p -71.92 44.65 0.11 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.435 1.494 . . . . 0.0 111.467 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 p -116.73 163.21 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.234 1.814 . . . . 0.0 107.04 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 73.63 -41.29 0.49 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.037 2.135 . . . . 0.0 111.911 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -67.08 -30.92 51.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 123.397 0.679 . . . . 0.0 111.334 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.4 t -75.92 120.14 80.34 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 122.978 0.511 . . . . 0.0 110.564 -174.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.42 -31.68 10.0 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.007 3.138 . . . . 0.0 115.0 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.82 3.77 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.045 0.938 . . . . 0.0 111.673 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 25.1 62.94 0.06 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.789 2.035 . . . . 0.0 113.535 -171.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.4 p -95.55 21.72 7.91 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.802 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.0 mp -90.0 120.52 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -136.13 145.98 46.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.887 0.875 . . . . 0.0 109.17 -174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.74 152.49 40.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 122.963 0.505 . . . . 0.0 111.439 -169.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.45 -143.36 5.2 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 161.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -57.37 -63.33 1.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.675 1.19 . . . . 0.0 111.061 -166.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -109.54 -57.17 2.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.175 1.39 . . . . 0.0 110.536 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -96.47 178.77 5.24 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.966 1.306 . . . . 0.0 109.617 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -86.26 165.63 16.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.636 0.732 . . . . 0.0 109.597 165.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -127.65 172.65 10.58 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.572 1.949 . . . . 0.0 106.773 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.1 mt -130.56 134.65 61.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.52 112.55 15.37 Favored Pre-proline 0 C--O 1.236 0.379 0 CA-C-N 120.67 1.577 . . . . 0.0 109.07 167.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -100.41 29.33 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.845 1.697 . . . . 0.0 110.056 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -109.72 -40.91 4.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.353 1.461 . . . . 0.0 108.443 162.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.6 -44.12 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.166 1.386 . . . . 0.0 110.323 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.4 t -51.61 121.0 5.75 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.246 0.476 . . . . 0.0 110.97 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -89.84 25.88 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.219 1.008 . . . . 0.0 112.122 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 49.58 41.78 21.96 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.758 1.223 . . . . 0.0 111.535 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 p -65.82 -40.65 92.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.435 -170.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.97 95.8 0.11 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -164.62 -58.29 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.409 1.083 . . . . 0.0 109.245 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.43 -38.44 43.26 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.651 1.18 . . . . 0.0 111.927 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.34 -33.28 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 0.0 112.453 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.54 84.23 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.919 -0.488 . . . . 0.0 111.23 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.9 m -86.48 -34.99 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.287 -0.387 . . . . 0.0 110.847 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.28 122.28 65.84 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.294 0.497 . . . . 0.0 111.943 -173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.98 118.56 5.28 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.067 1.845 . . . . 0.0 111.101 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.54 19.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.749 1.219 . . . . 0.0 111.407 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t 51.08 53.92 12.16 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.689 0.796 . . . . 0.0 110.521 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.8 62.02 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.82 -0.55 . . . . 0.0 110.458 171.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.58 114.76 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 162.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -125.83 149.27 48.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.797 0.839 . . . . 0.0 110.241 176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.01 149.52 37.55 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.412 ' O ' ' NZ ' ' A' ' 65' ' ' LYS . 3.4 tp10 -52.97 -25.78 13.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.772 0.796 . . . . 0.0 112.283 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.18 -50.76 66.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.78 -1.2 . . . . 0.0 110.08 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -71.36 -36.33 71.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.502 1.521 . . . . 0.0 110.743 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 t -54.6 127.62 59.69 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-O 119.232 -0.413 . . . . 0.0 111.094 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.42 152.78 75.07 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.039 1.826 . . . . 0.0 110.765 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -48.79 -44.97 39.55 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.403 1.081 . . . . 0.0 111.452 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.55 -55.28 4.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.089 1.423 . . . . 0.0 109.532 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . 0.303 48.8 m0 -83.46 3.54 31.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.254 -0.904 . . . . 0.0 113.382 -168.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 6.0 mptt -49.21 -34.22 14.27 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.109 -0.994 . . . . 0.0 110.195 152.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.7 m -53.01 -52.78 57.31 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.671 0.389 . . . . 0.0 111.185 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -64.83 -40.6 95.45 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.664 -0.648 . . . . 0.0 110.81 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -45.16 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 119.351 -0.94 . . . . 0.0 109.369 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -55.94 -42.41 76.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.397 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -57.26 -52.95 63.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.659 1.118 . . . . 0.0 112.377 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.615 HD21 HG22 ' A' ' 4' ' ' ILE . 4.6 m-80 -51.94 -44.59 63.99 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.505 0.722 . . . . 0.0 110.715 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -58.25 -53.44 58.29 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.663 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -53.74 -42.56 68.3 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.624 -174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -43.79 -43.91 6.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.601 1.16 . . . . 0.0 111.349 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.59 22.28 14.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.709 0.804 . . . . 0.0 111.337 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.1 ttpp -143.6 88.14 1.98 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -93.83 126.14 38.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -131.17 160.19 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-O 121.79 0.805 . . . . 0.0 109.383 -165.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -66.08 160.03 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.299 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.1 p -140.3 162.85 34.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 152.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -7.67 -67.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 128.92 2.888 . . . . 0.0 115.203 164.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.52 -11.9 5.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.723 2.282 . . . . 0.0 117.418 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.2 t -62.77 -35.56 80.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 121.047 1.749 . . . . 0.0 111.185 168.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.8 mt -50.72 122.54 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.432 1.093 . . . . 0.0 110.736 -167.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.09 -26.47 6.74 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -167.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.2 m 45.78 82.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.839 1.655 . . . . 0.0 112.711 169.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' NZ ' ' S4 ' ' A' ' 78' ' ' F3S . 1.1 pptp? -76.75 176.48 8.42 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.861 -173.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.3 -92.06 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.336 2.654 . . . . 0.0 114.504 -171.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.96 111.0 1.97 Allowed 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.2 m -114.69 144.68 43.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.692 0.758 . . . . 0.0 112.417 -160.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 p -35.44 -42.95 0.23 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.572 2.349 . . . . 0.0 112.534 171.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 p -40.9 -43.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.87 -26.24 67.25 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.05 -22.49 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -165.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.38 118.48 67.87 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.674 0.67 . . . . 0.0 112.497 -165.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -50.48 -38.29 53.56 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.617 2.878 . . . . 0.0 113.877 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 m -99.47 6.76 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.065 -175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.5 t0 33.28 64.41 0.3 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.597 1.559 . . . . 0.0 113.208 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -112.71 20.17 16.76 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.542 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.38 125.94 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 171.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -134.06 162.94 30.71 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -91.93 156.33 17.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 118.597 0.635 . . . . 0.0 111.78 -170.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.54 -154.97 9.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.639 1.114 . . . . 0.0 110.317 168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -56.75 -67.21 0.33 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.767 1.627 . . . . 0.0 110.079 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.15 -67.97 0.93 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 157.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -45.47 114.68 0.79 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 127.269 2.227 . . . . 0.0 111.626 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.9 157.63 32.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.736 -0.785 . . . . 0.0 109.393 166.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -127.22 174.2 9.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.871 1.668 . . . . 0.0 109.49 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 mt -132.7 131.65 59.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -68.76 114.37 22.2 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.939 1.245 . . . . 0.0 109.088 168.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -90.99 1.41 4.82 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.012 1.808 . . . . 0.0 111.757 -173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -92.65 -32.16 14.87 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 119.547 1.067 . . . . 0.0 108.439 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.98 -46.36 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.415 1.086 . . . . 0.0 110.586 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.5 t -49.24 123.48 7.46 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.205 0.526 . . . . 0.0 111.335 -175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pt -82.85 6.94 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 59.25 84.97 0.1 Allowed 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.932 1.693 . . . . 0.0 109.702 -172.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.85 -152.3 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.616 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.67 170.55 29.82 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 106.746 -2.542 . . . . 0.0 106.746 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 124.9 -52.56 0.01 OUTLIER 'General case' 0 C--O 1.233 0.235 0 C-N-CA 130.459 3.504 . . . . 0.0 108.321 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.9 p -65.74 -44.81 84.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.148 0.979 . . . . 0.0 111.028 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -43.11 99.13 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.425 -0.797 . . . . 0.0 110.82 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.37 82.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.366 0.666 . . . . 0.0 110.832 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -27.38 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.8 t -74.71 132.39 78.02 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 121.842 -0.536 . . . . 0.0 111.156 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.406 ' HD3' ' HE3' ' A' ' 12' ' ' LYS . 24.6 Cg_endo -61.27 117.95 4.78 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.226 2.617 . . . . 0.0 109.858 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 58.72 25.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.428 1.091 . . . . 0.0 110.739 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 t 50.96 54.48 11.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.628 0.771 . . . . 0.0 110.834 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -32.98 59.47 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.678 -0.639 . . . . 0.0 110.317 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 75.8 mt -62.32 110.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 161.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.77 150.18 47.97 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.666 1.187 . . . . 0.0 110.117 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -72.7 146.4 46.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -38.46 -44.47 0.94 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.529 1.532 . . . . 0.0 112.088 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.68 -50.62 73.21 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.743 1.617 . . . . 0.0 110.877 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -71.58 -31.44 66.96 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.194 1.398 . . . . 0.0 110.036 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.7 t -64.39 127.44 92.2 Favored Pre-proline 0 N--CA 1.451 -0.375 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -66.21 149.02 85.62 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.974 1.783 . . . . 0.0 109.727 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -49.53 -38.61 31.33 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 127.399 2.28 . . . . 0.0 112.572 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.33 -58.57 2.49 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.96 1.362 . . . . 0.0 109.347 167.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 52.2 m0 -88.11 -0.93 57.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.884 1.274 . . . . 0.0 113.466 -172.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -35.18 17.78 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.729 157.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -50.77 -48.33 59.39 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.653 0.781 . . . . 0.0 111.493 171.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -66.2 -39.34 89.59 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.688 -0.633 . . . . 0.0 111.094 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -47.48 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -59.56 -39.16 83.15 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.713 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.67 -49.87 76.07 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.486 1.039 . . . . 0.0 111.93 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -54.7 -46.5 74.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -53.46 -55.66 23.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.35 -42.63 70.46 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.806 0.842 . . . . 0.0 111.545 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -47.02 -39.59 13.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.839 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -112.35 23.41 13.66 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.045 0.938 . . . . 0.0 111.578 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -146.77 66.44 1.17 Allowed 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -172.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 mtmm . . . . . 0 C--O 1.253 1.275 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 174.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . 0.482 ' S4 ' ' NZ ' ' A' ' 12' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' ILE . 95.0 m-85 -131.76 137.27 48.13 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 120.232 1.378 . . . . 0.0 107.553 168.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.19 158.8 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.39 1.076 . . . . 0.0 109.292 -159.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -66.89 159.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.402 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.477 ' CG2' HG22 ' A' ' 60' ' ' VAL . 66.9 p -130.48 -153.54 0.57 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 155.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -73.36 -54.47 4.12 Favored Pre-proline 0 N--CA 1.438 -1.045 0 C-N-CA 128.867 2.867 . . . . 0.0 112.395 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.32 -28.93 28.38 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.969 1.779 . . . . 0.0 116.139 -172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -56.67 -36.92 70.15 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.429 -0.794 . . . . 0.0 112.303 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.1 mt -35.53 120.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.632 1.573 . . . . 0.0 113.795 -160.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.67 12.27 80.36 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.542 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.1 m 75.91 164.29 0.26 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.944 1.297 . . . . 0.0 110.251 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 163.78 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.462 1.505 . . . . 0.0 107.795 168.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -44.95 -65.28 0.55 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.811 2.045 . . . . 0.0 113.218 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.8 64.13 1.75 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.281 1.033 . . . . 0.0 109.967 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -62.16 155.11 25.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.753 0.821 . . . . 0.0 112.097 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.8 p -79.27 -64.49 1.17 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.675 1.19 . . . . 0.0 109.815 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 18' ' ' GLU 0.263 15.9 m 22.38 -87.17 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 127.977 2.511 . . . . 0.0 115.908 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' H ' HG23 ' A' ' 17' ' ' VAL . 11.0 pt-20 -71.49 -20.35 62.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.061 0.944 . . . . 0.0 113.191 -165.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.5 m -68.23 -23.11 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 112.693 -172.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.81 119.65 75.52 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -166.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.21 -26.07 14.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 124.062 3.174 . . . . 0.0 114.972 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.02 24.47 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.827 0.851 . . . . 0.0 111.076 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 69.83 -28.35 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 164.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.53 42.71 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -145.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.64 134.97 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 161.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -131.03 169.25 16.1 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.718 1.207 . . . . 0.0 109.196 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -103.27 153.46 20.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.12 -131.68 3.95 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 163.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -61.82 -62.3 1.89 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.412 1.085 . . . . 0.0 110.43 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -133.87 -54.12 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.383 2.673 . . . . 0.0 106.69 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -44.73 147.01 0.67 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.904 2.082 . . . . 0.0 112.385 163.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -105.03 162.2 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.108 0.963 . . . . 0.0 108.959 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -137.62 172.42 12.99 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.113 0.965 . . . . 0.0 109.808 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.1 mt -136.52 141.12 41.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -77.83 113.13 29.87 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 119.213 0.915 . . . . 0.0 109.39 166.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -89.04 4.28 5.37 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 121.667 1.578 . . . . 0.0 111.914 -172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -94.56 -40.02 10.07 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 172.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.64 -46.21 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 124.215 1.006 . . . . 0.0 109.855 174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.4 t -51.89 115.51 1.71 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.521 0.677 . . . . 0.0 111.017 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 4.5 pt -68.9 -10.94 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.041 0.937 . . . . 0.0 113.298 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.8 t70 76.44 94.9 0.07 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.591 1.956 . . . . 0.0 108.559 -171.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.75 150.15 33.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.311 0.645 . . . . 0.0 109.693 -173.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -99.63 48.03 1.28 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.09 0.405 . . . . 0.0 112.236 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.77 -64.85 1.01 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.479 0.639 . . . . 0.0 109.96 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 p -57.2 -47.05 82.24 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.53 0.732 . . . . 0.0 111.664 -175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -50.13 -44.56 52.42 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.614 0.643 . . . . 0.0 111.401 177.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.33 90.81 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.733 -171.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 m -85.2 -34.67 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 119.026 -0.512 . . . . 0.0 111.601 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 42.2 t -55.13 123.48 48.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 118.411 0.55 . . . . 0.0 110.973 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -54.24 120.46 8.02 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.0 1.8 . . . . 0.0 111.089 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.77 19.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.479 1.112 . . . . 0.0 111.387 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 t 48.05 55.32 8.84 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.417 1.087 . . . . 0.0 110.718 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.81 -31.97 59.81 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 122.032 -0.418 . . . . 0.0 110.331 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' A' ' 2' ' ' TYR . 81.6 mt -65.74 114.96 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 165.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.23 153.59 51.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.166 1.386 . . . . 0.0 110.258 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -73.94 146.96 43.54 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.689 -0.632 . . . . 0.0 109.865 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -41.29 -43.11 2.34 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 112.352 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -58.13 -60.07 4.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.53 0.732 . . . . 0.0 109.452 -178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -61.71 -35.16 77.23 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 127.642 2.377 . . . . 0.0 109.994 -178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.477 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.5 t -59.56 126.0 81.29 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.419 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -61.34 149.88 87.44 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.573 1.516 . . . . 0.0 109.483 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -47.96 -44.04 29.92 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 127.039 2.136 . . . . 0.0 111.32 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -41.03 -48.84 3.32 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.058 0.943 . . . . 0.0 111.354 169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -100.82 -4.78 27.28 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.96 1.704 . . . . 0.0 113.478 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -51.98 -31.73 30.56 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.077 -1.014 . . . . 0.0 109.809 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -48.91 -52.08 26.49 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.274 1.43 . . . . 0.0 112.569 166.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -62.77 -37.05 85.12 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.502 -0.749 . . . . 0.0 110.532 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.92 -46.5 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -53.32 -39.63 64.2 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.025 169.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -63.7 -50.23 69.99 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.69 0.677 . . . . 0.0 112.56 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 4' ' ' ILE . 3.2 m-80 -52.48 -45.73 66.27 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 119.174 0.897 . . . . 0.0 110.797 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -54.31 -56.71 15.78 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.95 -46.58 71.64 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.576 0.703 . . . . 0.0 112.1 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -41.32 -50.54 3.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 109.821 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -107.45 15.16 25.15 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -174.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -81.47 -33.35 32.04 Favored 'General case' 0 C--N 1.335 -0.045 0 O-C-N 122.047 -0.408 . . . . 0.0 111.591 -174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 C-N-CA 127.157 2.183 . . . . 0.0 106.861 -167.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.292 . . . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.8 128.85 44.16 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.056 1.342 . . . . 0.0 109.644 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -140.13 160.86 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 121.721 0.772 . . . . 0.0 111.765 -166.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -70.84 162.38 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.309 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.444 ' CG2' HG22 ' A' ' 60' ' ' VAL . 15.4 p -131.64 -86.94 0.48 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.065 0.546 . . . . 0.0 110.488 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -152.65 -53.55 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.034 0.934 . . . . 0.0 110.699 -153.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.96 21.84 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 N-CA-C 117.563 2.101 . . . . 0.0 117.563 177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -126.91 -3.12 6.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 121.105 1.775 . . . . 0.0 111.631 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.3 mm -43.52 116.74 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.603 0 CA-C-N 120.564 1.529 . . . . 0.0 110.771 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.83 -16.04 26.01 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.236 1.398 . . . . 0.0 112.585 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.0 m 73.66 83.84 0.12 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.435 1.894 . . . . 0.0 108.684 -169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -56.96 -66.15 0.5 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -165.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -160.79 -96.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -155.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.39 156.55 37.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.506 1.146 . . . . 0.0 113.562 -165.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 p -90.13 67.98 7.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.856 1.262 . . . . 0.0 110.506 -174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -40.7 -46.91 2.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.859 0.864 . . . . 0.0 111.247 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 p -36.08 -48.19 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.146 1.379 . . . . 0.0 114.257 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.22 -28.37 69.32 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.465 -0.772 . . . . 0.0 112.63 -173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.51 -16.09 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.585 0.63 . . . . 0.0 112.143 -168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -76.0 124.61 88.49 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 121.999 -0.438 . . . . 0.0 111.882 -167.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.55 -41.71 71.49 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.469 2.779 . . . . 0.0 113.366 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -119.48 71.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -43.55 110.13 0.18 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.186 0.995 . . . . 0.0 111.714 -173.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 30.2 p -149.84 29.07 0.75 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.367 1.467 . . . . 0.0 109.156 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.38 125.14 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -132.06 176.78 8.08 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.269 1.427 . . . . 0.0 108.356 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -98.81 148.07 24.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.034 -0.416 . . . . 0.0 110.875 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -124.61 179.78 16.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.144 -1.583 . . . . 0.0 109.144 165.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -57.45 -58.65 7.35 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.553 1.168 . . . . 0.0 111.684 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.83 -56.62 4.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.983 3.313 . . . . 0.0 109.804 -174.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -144.58 171.43 14.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.52 1.128 . . . . 0.0 109.007 -170.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -80.84 147.02 30.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -115.74 174.37 6.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.342 1.857 . . . . 0.0 109.315 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.05 148.86 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.24 107.86 13.6 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.995 1.271 . . . . 0.0 109.734 162.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -73.12 -17.51 24.62 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.063 1.176 . . . . 0.0 113.832 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -84.18 -32.28 24.68 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.4 t -72.26 -49.67 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.409 0.684 . . . . 0.0 109.758 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 15.7 t -53.29 140.3 27.21 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.034 0.445 . . . . 0.0 110.159 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.61 29.75 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.469 0.707 . . . . 0.0 112.635 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 50.72 46.96 25.23 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.554 0.693 . . . . 0.0 112.736 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 -25.27 24.15 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.19 -130.77 16.64 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -167.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 65.16 -69.48 0.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.14 1.776 . . . . 0.0 111.779 -176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.0 p -48.45 -46.12 37.44 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.458 1.103 . . . . 0.0 110.205 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -39.2 -50.86 1.95 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.979 1.712 . . . . 0.0 112.457 170.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.7 -41.05 46.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.89 0.476 . . . . 0.0 110.013 -172.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.68 -38.22 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 122.372 0.269 . . . . 0.0 110.875 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.8 t -57.63 115.7 11.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.398 1.079 . . . . 0.0 110.487 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -60.73 115.12 2.47 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.549 1.499 . . . . 0.0 109.923 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t 69.95 27.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.836 1.654 . . . . 0.0 110.989 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.1 m 31.92 60.3 0.32 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.789 2.035 . . . . 0.0 114.131 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.97 72.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 169.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 98.1 mt -71.17 111.6 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -129.66 155.52 45.72 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.346 1.458 . . . . 0.0 109.453 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -70.81 141.45 51.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.128 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -51.49 -28.81 14.44 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.3 -44.29 12.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.598 0.636 . . . . 0.0 112.18 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -55.71 -37.05 67.9 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 108.848 175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 5' ' ' THR . 3.0 t -49.75 127.06 19.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.41 172.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.94 155.75 68.52 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.574 2.182 . . . . 0.0 110.301 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -45.77 -43.31 13.0 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.93 2.092 . . . . 0.0 112.389 176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -47.95 -46.8 32.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.455 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -99.27 -3.62 33.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -49.03 -33.9 12.24 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.837 1.198 . . . . 0.0 109.62 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 m -45.74 -54.49 7.82 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.099 1.36 . . . . 0.0 112.074 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -65.41 -35.86 82.21 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 121.907 -0.495 . . . . 0.0 110.974 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -62.52 -50.58 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.41 -41.83 81.1 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.89 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -55.61 -56.93 14.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 120.036 1.289 . . . . 0.0 112.544 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -48.86 -49.25 40.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.568 0.747 . . . . 0.0 109.402 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -59.65 -35.04 73.61 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.974 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -43.71 58.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.931 -1.106 . . . . 0.0 109.523 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -47.55 -39.13 15.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.332 1.453 . . . . 0.0 112.953 -172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.88 -4.31 15.28 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.253 11.6 tppt? -10.36 -108.4 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -130.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -171.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' N ' ' OD2' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -102.54 124.25 47.75 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.771 1.228 . . . . 0.0 109.149 -174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 36' ' ' PRO . 1.9 t -131.97 152.73 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 CA-C-O 122.442 1.115 . . . . 0.0 110.572 -163.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.44 HG22 HD21 ' A' ' 71' ' ' ASN . 1.7 tp -60.13 153.74 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.719 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.7 p -140.2 170.04 16.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.438 0.637 . . . . 0.0 109.901 164.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -18.67 -65.37 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 128.295 2.638 . . . . 0.0 115.031 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.2 -27.14 36.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.546 2.164 . . . . 0.0 116.362 -171.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -68.97 -33.61 73.97 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.94 -1.1 . . . . 0.0 111.18 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -50.97 124.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 123.596 0.759 . . . . 0.0 109.465 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.36 -27.2 4.18 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 119.27 -0.739 . . . . 0.0 112.858 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -64.21 -41.81 96.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.049 1.425 . . . . 0.0 107.324 162.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 tttm 80.89 -58.91 0.28 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 150.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.83 113.62 11.06 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 124.716 1.206 . . . . 0.0 109.447 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -161.85 169.97 20.32 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.669 0.788 . . . . 0.0 108.978 170.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.8 m -74.84 36.46 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 115.983 1.845 . . . . 0.0 115.983 -159.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 p -70.26 -51.64 29.05 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 161.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 p -40.5 -40.26 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.888 1.675 . . . . 0.0 114.147 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -61.82 -32.6 72.93 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 m -96.65 -23.15 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -153.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.0 t -63.4 116.64 27.17 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 119.427 1.012 . . . . 0.0 113.613 -159.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.25 -29.51 38.31 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.613 2.875 . . . . 0.0 114.034 176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 m -114.83 29.36 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.866 0.866 . . . . 0.0 110.718 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 73.23 -44.73 0.6 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.57 1.948 . . . . 0.0 114.495 165.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.8 t -77.76 68.92 3.92 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -157.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.77 105.92 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.419 -2.808 . . . . 0.0 103.419 143.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.512 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -110.32 -172.2 1.99 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.602 1.161 . . . . 0.0 109.133 -178.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 136.03 50.02 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.296 1.438 . . . . 0.0 111.303 -168.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.63 -147.01 9.67 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -60.67 -63.33 1.33 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.388 1.475 . . . . 0.0 110.528 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -105.12 -73.67 0.67 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.64 169.54 18.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.984 1.314 . . . . 0.0 111.639 -174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -77.08 158.79 30.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.963 166.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -126.6 172.54 10.18 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.893 1.677 . . . . 0.0 107.865 173.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 mt -130.37 148.01 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -90.68 105.97 13.77 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 120.362 1.437 . . . . 0.0 108.426 162.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HB3' HG22 ' A' ' 3' ' ' VAL . 55.3 Cg_endo -61.31 -23.87 77.72 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.762 1.641 . . . . 0.0 112.086 -177.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -76.02 -22.86 55.32 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 119.229 0.922 . . . . 0.0 110.449 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.27 -47.59 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.226 0.61 . . . . 0.0 109.621 172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 t -50.29 124.53 10.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.257 0.623 . . . . 0.0 111.703 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.41 16.19 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.144 0.978 . . . . 0.0 113.259 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 3.5 t70 58.43 59.86 2.82 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.487 1.915 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.51 -23.47 16.01 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.442 -173.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.58 -27.56 2.17 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.258 -0.901 . . . . 0.0 114.713 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.09 -47.05 45.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.29 1.045 . . . . 0.0 113.08 -170.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.4 p -58.49 -46.26 87.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.34 -177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.28 -43.64 83.28 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.433 1.015 . . . . 0.0 110.551 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.54 -36.51 76.29 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.008 -0.432 . . . . 0.0 111.125 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.23 -34.34 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.077 0.551 . . . . 0.0 111.661 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.3 t -53.05 113.31 4.47 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.564 1.146 . . . . 0.0 109.233 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.15 -35.32 72.67 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.106 2.538 . . . . 0.0 113.186 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.5 t -85.18 -24.39 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.513 0.725 . . . . 0.0 110.556 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m 56.0 78.37 0.2 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.972 1.309 . . . . 0.0 109.13 -165.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -122.43 -1.31 9.13 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.2 1.8 . . . . 0.0 111.483 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.1 mt -97.9 73.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.0 148.99 25.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.495 -167.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -71.18 137.96 49.17 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -173.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -49.79 -29.52 7.97 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.38 -53.05 9.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.113 0.965 . . . . 0.0 110.611 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -63.14 -34.52 77.8 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.158 2.183 . . . . 0.0 110.131 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -46.76 124.75 7.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 123.857 0.863 . . . . 0.0 109.51 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.9 148.81 91.29 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.699 1.599 . . . . 0.0 109.6 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -45.05 -44.96 10.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.174 2.19 . . . . 0.0 111.591 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -44.35 -48.86 9.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.555 0.742 . . . . 0.0 111.263 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -98.2 -4.86 34.56 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.795 1.638 . . . . 0.0 113.123 -173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -52.77 -30.11 31.06 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.402 160.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -52.71 -51.24 61.22 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 0.0 112.265 167.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -63.69 -38.01 89.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.356 -0.84 . . . . 0.0 110.386 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.58 -45.54 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.18 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.8 -37.11 68.19 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.735 169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -64.17 -53.0 56.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.879 1.218 . . . . 0.0 112.131 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.44 HD21 HG22 ' A' ' 4' ' ' ILE . 3.6 m-80 -52.2 -38.1 56.87 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.356 -0.84 . . . . 0.0 111.5 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 mtt85 -62.27 -61.35 2.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.576 0.626 . . . . 0.0 109.9 167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -43.09 -45.53 5.36 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.672 1.989 . . . . 0.0 112.58 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -44.49 -34.17 1.98 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.155 -1.839 . . . . 0.0 112.384 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 30.3 m-85 -125.17 16.14 8.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.421 1.088 . . . . 0.0 113.445 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 132.18 28.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 119.234 0.925 . . . . 0.0 110.415 -170.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.363 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 163.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.38 0 CA-C-O 120.956 0.407 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -93.85 121.59 35.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.806 1.242 . . . . 0.0 108.723 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.81 161.56 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 122.509 1.147 . . . . 0.0 109.273 -167.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 71' ' ' ASN . 1.2 tp -66.31 166.86 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.793 -178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.422 ' CG2' HG22 ' A' ' 60' ' ' VAL . 25.1 p -134.0 -99.43 0.26 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 158.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 9' ' ' ILE . 4.1 tp10 -143.47 -49.85 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.525 1.53 . . . . 0.0 110.567 -151.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -51.4 -20.79 9.04 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 CA-C-N 122.186 1.816 . . . . 0.0 114.776 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.06 -28.32 69.39 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.394 1.078 . . . . 0.0 113.611 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 6' ' ' GLU . 26.5 mm -40.3 120.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 -163.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.94 12.49 59.01 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.309 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.9 m 63.97 57.09 1.35 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -60.45 106.97 0.6 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.552 -169.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 85.76 -60.7 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 128.514 2.725 . . . . 0.0 111.754 165.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.66 -161.73 1.16 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.785 1.234 . . . . 0.0 108.999 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.7 t -143.89 164.81 29.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 p -108.34 9.4 27.83 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.12 2.168 . . . . 0.0 110.544 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.02 161.3 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.371 172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 71.91 -37.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.082 3.353 . . . . 0.0 113.624 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.0 m -72.03 -29.34 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.805 -0.559 . . . . 0.0 111.73 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.0 t -70.56 123.75 89.63 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 122.937 0.495 . . . . 0.0 111.129 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -48.35 -36.88 31.31 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.905 3.07 . . . . 0.0 114.128 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.32 47.97 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.761 1.224 . . . . 0.0 108.691 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -41.97 108.65 0.1 Allowed 'General case' 0 C--N 1.343 0.298 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.5 t -134.96 40.05 2.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 169.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.69 126.27 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -134.69 173.56 11.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.579 0.752 . . . . 0.0 109.849 -174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.14 156.47 16.38 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.606 0.362 . . . . 0.0 110.423 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.33 -163.07 12.02 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 124.554 1.073 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -46.29 -58.65 3.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.057 1.743 . . . . 0.0 111.127 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -127.8 -56.81 1.28 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.13 1.772 . . . . 0.0 109.59 -174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -76.71 177.52 7.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.487 1.115 . . . . 0.0 111.442 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.4 m-30 -102.29 171.54 7.42 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -134.88 171.95 13.67 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 126.226 1.81 . . . . 0.0 111.375 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.5 mt -130.67 137.12 56.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 171.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.38 115.06 28.63 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 120.221 1.373 . . . . 0.0 109.438 165.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -88.78 1.21 6.26 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.884 1.723 . . . . 0.0 111.461 -172.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.11 -27.76 14.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 119.357 0.981 . . . . 0.0 108.426 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.72 -46.91 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.194 0.998 . . . . 0.0 110.364 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 28.0 t -50.25 125.03 11.51 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 111.129 -177.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.3 pt -83.61 5.31 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 m-20 60.44 83.88 0.13 Allowed 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 126.113 1.765 . . . . 0.0 108.908 -170.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.41 176.72 7.5 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.15 121.98 4.79 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 175.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -179.71 -60.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.406 1.882 . . . . 0.0 108.769 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.7 p -59.9 -43.22 94.96 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.532 1.133 . . . . 0.0 111.713 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -38.27 90.49 Favored 'General case' 0 C--O 1.231 0.097 0 O-C-N 121.422 -0.799 . . . . 0.0 110.785 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.1 -44.43 95.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.378 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.63 -33.26 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.036 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -53.47 112.01 3.28 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.186 0.903 . . . . 0.0 109.966 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.82 115.51 3.13 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.711 1.608 . . . . 0.0 109.361 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t 65.03 42.03 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.881 1.272 . . . . 0.0 110.043 -175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 m 11.71 77.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.583 2.753 . . . . 0.0 115.078 169.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.84 -31.67 69.66 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 109.942 164.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.0 mt -64.48 117.29 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -134.45 153.67 51.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.575 1.15 . . . . 0.0 110.336 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -71.62 138.95 49.11 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -48.87 -32.52 9.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -73.01 -52.41 14.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.111 0.965 . . . . 0.0 110.576 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -62.79 -34.7 77.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.57 1.948 . . . . 0.0 109.803 -178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.3 t -49.88 123.83 15.75 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.443 175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -59.95 150.51 77.81 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.985 1.79 . . . . 0.0 109.92 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -46.11 -46.17 16.86 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 127.243 2.217 . . . . 0.0 111.331 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -41.79 -47.65 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.634 1.174 . . . . 0.0 111.614 170.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -99.44 -6.53 27.5 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.038 1.735 . . . . 0.0 113.595 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -53.02 -30.69 36.95 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.9 -1.125 . . . . 0.0 109.64 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.1 m -49.38 -51.32 35.72 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.805 1.242 . . . . 0.0 112.283 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -63.51 -39.3 94.06 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 121.508 -0.745 . . . . 0.0 110.296 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -48.26 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 -176.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.15 -43.09 70.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.163 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -59.88 -50.41 73.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.422 1.01 . . . . 0.0 112.902 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 4' ' ' ILE . 2.2 m-80 -53.26 -47.57 68.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.123 0.874 . . . . 0.0 109.693 175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -53.61 -56.47 16.88 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 172.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -52.92 -45.04 67.43 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.904 0.882 . . . . 0.0 111.433 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -37.31 10.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 124.839 1.337 . . . . 0.0 112.419 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -112.16 16.25 20.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.505 0.722 . . . . 0.0 112.085 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -111.58 -35.79 5.68 Favored 'General case' 0 CA--C 1.522 -0.114 0 C-N-CA 124.314 1.046 . . . . 0.0 111.131 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -146.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 1.295 . . . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.98 125.7 36.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 150.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.73 155.77 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 124.65 1.18 . . . . 0.0 109.525 -161.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.576 HG22 HD21 ' A' ' 71' ' ' ASN . 3.4 tp -63.87 161.5 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 O-C-N 122.058 -0.401 . . . . 0.0 110.318 178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 p -126.5 -96.65 0.43 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 158.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.36 -58.86 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.308 -148.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -47.67 -28.94 10.04 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.106 1.87 . . . . 0.0 115.982 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.0 t -61.46 -34.34 75.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.673 0.67 . . . . 0.0 111.907 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.3 mt -39.99 121.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.457 1.503 . . . . 0.0 111.862 -168.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.51 -26.81 18.08 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.777 1.179 . . . . 0.0 112.436 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -68.46 -56.14 9.41 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.116 0.958 . . . . 0.0 109.249 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp 65.85 -64.34 0.2 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.346 1.858 . . . . 0.0 113.794 175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -108.38 89.37 2.97 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.449 1.1 . . . . 0.0 109.69 -169.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.04 -157.95 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.372 0.669 . . . . 0.0 110.684 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -42.12 -36.56 1.2 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 128.001 2.52 . . . . 0.0 116.417 -163.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.0 p -68.83 -19.52 64.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.66 1.184 . . . . 0.0 112.174 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -49.9 117.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 O-C-N 121.664 -0.647 . . . . 0.0 112.009 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.79 16.24 4.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.427 1.891 . . . . 0.0 115.623 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.1 m -79.56 -20.85 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 119.978 1.263 . . . . 0.0 111.683 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.4 t -70.72 120.52 79.5 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.493 0.717 . . . . 0.0 112.336 -166.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.03 -34.72 23.86 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.908 3.072 . . . . 0.0 114.099 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.81 33.67 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.757 0.823 . . . . 0.0 110.261 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.272 0.6 OUTLIER 62.72 -39.83 0.16 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 159.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -79.32 62.95 3.82 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.643 1.565 . . . . 0.0 114.361 -156.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.37 115.12 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 155.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -122.38 177.13 5.52 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.354 0.661 . . . . 0.0 109.72 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -99.81 138.07 37.39 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.48 -138.65 9.42 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 166.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -63.34 -63.41 1.2 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.313 1.045 . . . . 0.0 110.674 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.9 -69.81 0.83 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.471 1.508 . . . . 0.0 108.395 -178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -87.31 174.21 8.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.168 0.987 . . . . 0.0 110.555 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -72.15 165.15 24.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.661 168.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -131.03 170.67 14.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 164.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.4 mp -125.26 145.62 32.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -78.03 109.44 10.05 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.74 1.29 8.15 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.652 2.235 . . . . 0.0 111.293 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -98.73 -31.77 11.72 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.1 t -71.11 -47.81 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.98 0.912 . . . . 0.0 109.744 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.7 t -52.03 129.74 28.05 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.786 0.803 . . . . 0.0 111.3 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.0 14.08 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 116.854 -1.546 . . . . 0.0 113.51 -172.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 53.81 93.54 0.02 OUTLIER 'General case' 0 C--N 1.35 0.611 0 CA-C-N 121.265 1.848 . . . . 0.0 112.477 -166.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.6 163.43 33.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.791 -0.568 . . . . 0.0 110.014 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.51 8.17 66.32 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 122.069 -0.395 . . . . 0.0 113.592 -171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.37 -67.34 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.467 1.134 . . . . 0.0 110.868 -172.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 p -55.44 -48.41 74.51 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.642 0.777 . . . . 0.0 110.553 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -39.25 -55.84 1.62 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.013 1.725 . . . . 0.0 111.488 174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.88 95.12 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.9 m -89.12 -26.67 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -171.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.3 t -64.7 126.48 90.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.704 0.684 . . . . 0.0 110.233 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -49.93 120.55 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.764 2.31 . . . . 0.0 111.922 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t 58.2 22.48 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.352 1.061 . . . . 0.0 111.316 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.8 p 43.33 57.23 3.92 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.648 1.179 . . . . 0.0 110.963 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.12 67.73 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.934 -0.479 . . . . 0.0 110.378 174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.2 mt -65.97 111.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 162.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -121.59 145.38 48.04 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.885 1.274 . . . . 0.0 110.584 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.03 144.27 56.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.321 1.048 . . . . 0.0 109.704 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -56.61 -16.91 6.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.31 -59.07 2.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.852 0.751 . . . . 0.0 109.144 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -61.95 -37.64 85.48 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 128.478 2.711 . . . . 0.0 110.298 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 68' ' ' ILE . 2.7 t -48.84 129.19 14.54 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.601 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.18 149.79 88.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.465 1.443 . . . . 0.0 109.755 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -45.53 -45.83 13.63 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 127.408 2.283 . . . . 0.0 111.688 176.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -42.54 -46.74 4.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.981 0.913 . . . . 0.0 111.497 171.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -100.71 0.43 38.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.156 1.382 . . . . 0.0 113.55 -174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -53.01 -32.35 46.13 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.043 1.292 . . . . 0.0 109.456 162.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 m -43.17 -54.14 4.63 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.989 1.315 . . . . 0.0 112.262 167.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -64.67 -36.68 85.06 Favored 'General case' 0 CA--C 1.511 -0.54 0 O-C-N 121.637 -0.664 . . . . 0.0 110.862 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -66.3 -45.45 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -176.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.07 -39.05 74.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.177 170.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -59.41 -55.06 39.46 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.991 0.814 . . . . 0.0 112.629 174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.576 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -51.63 -41.89 61.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.839 0.856 . . . . 0.0 110.611 173.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -56.75 17.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.853 0.752 . . . . 0.0 109.65 170.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.51 -44.27 68.97 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.91 1.284 . . . . 0.0 111.791 -171.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -46.21 -34.72 4.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 112.667 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.29 31.88 6.38 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 111.395 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -154.42 97.85 2.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.423 ' OXT' ' NZ ' ' A' ' 77' ' ' LYS 0.314 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 C-N-CA 128.382 2.673 . . . . 0.0 116.123 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.477 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.303 . . . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.66 126.0 48.42 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.551 1.54 . . . . 0.0 108.646 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.8 t -138.73 158.05 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 122.287 1.042 . . . . 0.0 111.503 -161.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 71' ' ' ASN . 2.5 tp -64.11 159.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.259 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 ' CG2' HG22 ' A' ' 60' ' ' VAL . 55.4 p -141.68 167.24 22.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 161.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -13.11 -64.81 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.381 2.672 . . . . 0.0 115.305 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -49.44 -31.04 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.937 2.425 . . . . 0.0 116.881 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.32 -27.31 67.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.799 1.181 . . . . 0.0 110.841 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 99.0 mt -51.87 126.71 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 O-C-N 121.229 -0.919 . . . . 0.0 110.117 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.42 -55.23 4.49 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m -49.04 142.41 6.74 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.646 1.179 . . . . 0.0 112.334 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -141.62 94.44 2.68 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.44 -164.25 1.15 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 156.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.43 -27.17 3.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.916 2.086 . . . . 0.0 109.272 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.2 m -42.77 -47.26 5.43 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -66.98 -38.14 85.5 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.24 -48.03 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 120.058 1.299 . . . . 0.0 112.52 -165.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -81.48 -19.05 43.11 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -168.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.7 -19.8 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -168.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 41.1 t -75.26 119.89 79.08 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -165.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.77 -34.27 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.105 3.203 . . . . 0.0 114.363 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.3 m -116.39 27.03 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.1 0.96 . . . . 0.0 110.931 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 p30 46.3 11.87 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.8 p -84.09 8.91 13.97 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.404 -1.435 . . . . 0.0 114.738 -163.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 3.0 mp -74.0 106.09 3.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.484 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -117.27 -177.24 3.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.893 0.877 . . . . 0.0 109.405 177.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -105.25 140.67 38.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.244 1.018 . . . . 0.0 110.987 -170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.93 -141.97 7.96 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 166.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 -59.64 -63.14 1.41 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.682 1.193 . . . . 0.0 109.943 -171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.99 -73.46 0.66 Allowed 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 124.864 1.266 . . . . 0.0 107.941 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.86 167.05 12.17 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.036 0.922 . . . . 0.0 110.971 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -79.27 161.26 26.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.015 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -126.73 169.65 12.95 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.6 mt -133.57 130.9 57.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -71.83 110.79 8.48 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 119.758 1.163 . . . . 0.0 108.473 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -75.46 -15.97 19.48 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.276 1.317 . . . . 0.0 113.099 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.41 -26.82 15.19 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.234 1.014 . . . . 0.0 108.287 -170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.87 -48.98 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 123.613 0.765 . . . . 0.0 109.616 160.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.477 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 22.3 t -53.26 137.92 33.46 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.394 0.616 . . . . 0.0 110.334 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.28 22.33 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 48.82 77.07 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.212 0.915 . . . . 0.0 111.539 -167.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -122.89 172.11 8.72 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.759 0.824 . . . . 0.0 109.659 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.64 6.82 22.43 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.247 0.451 . . . . 0.0 113.688 -170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.09 -62.74 1.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.41 -1.053 . . . . 0.0 110.493 -174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.21 -43.72 92.29 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.625 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -43.94 -53.75 5.92 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.856 1.262 . . . . 0.0 111.394 172.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.83 -46.64 84.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.821 -0.172 . . . . 0.0 111.101 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -37.85 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.9 t -60.14 129.14 88.29 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.115 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.68 119.08 4.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.535 2.156 . . . . 0.0 111.861 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t 59.68 20.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.388 1.075 . . . . 0.0 111.363 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.0 m 48.46 54.11 10.97 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.413 1.085 . . . . 0.0 111.363 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.44 59.21 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.995 -0.441 . . . . 0.0 110.153 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.46 106.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 164.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -119.23 155.69 31.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.237 1.415 . . . . 0.0 110.875 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -72.47 140.27 48.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.923 -0.485 . . . . 0.0 110.377 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -51.55 -29.2 16.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 -166.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -93.66 -34.78 13.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.678 0.672 . . . . 0.0 112.582 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -61.04 -38.69 87.04 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.189 1.396 . . . . 0.0 108.58 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG22 ' CG2' ' A' ' 5' ' ' THR . 2.2 t -43.87 126.83 4.2 Favored Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 124.754 1.222 . . . . 0.0 109.826 171.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -54.11 144.41 58.43 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.277 1.985 . . . . 0.0 109.925 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -47.86 -46.06 30.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.199 1.8 . . . . 0.0 112.25 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.91 -62.55 0.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.651 1.581 . . . . 0.0 109.418 166.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -83.83 -8.62 59.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.972 1.309 . . . . 0.0 112.867 -173.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -56.05 -25.41 44.86 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.154 -0.966 . . . . 0.0 109.458 163.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 m -57.62 -51.88 67.7 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.361 -0.837 . . . . 0.0 112.247 165.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -59.26 -37.25 77.12 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 121.487 -0.758 . . . . 0.0 110.323 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.431 HG12 HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -63.45 -47.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.237 -178.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -57.6 -36.92 72.4 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.373 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -59.84 -54.07 50.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.402 1.001 . . . . 0.0 112.238 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 HD21 HG22 ' A' ' 4' ' ' ILE . 3.4 m-80 -50.3 -43.53 53.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.203 0.601 . . . . 0.0 111.12 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -59.35 -54.33 47.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.962 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -51.98 -44.09 63.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 124.952 1.301 . . . . 0.0 111.543 -172.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -46.38 -36.26 6.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.848 1.659 . . . . 0.0 112.73 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 95.4 m-85 -110.36 12.13 23.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.352 0.661 . . . . 0.0 112.395 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -108.16 -38.97 5.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.302 1.041 . . . . 0.0 110.734 -173.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HZ3' ' C ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 115.897 -2.001 . . . . 0.0 108.224 -146.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 41' ' ' ASP . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -89.22 128.11 35.8 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 68' ' ' ILE . 1.4 t -132.95 160.5 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.752 0.787 . . . . 0.0 110.116 -165.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 tp -68.3 157.59 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.652 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.9 p -118.93 -94.54 0.5 Allowed 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 159.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.05 -58.99 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.753 -148.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -49.96 -27.0 15.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 121.879 1.72 . . . . 0.0 116.1 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -59.18 -32.16 69.66 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.867 0.758 . . . . 0.0 111.858 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . 86.4 mt -45.83 125.73 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 124.081 0.952 . . . . 0.0 111.742 -168.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.69 -48.0 0.98 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 m -63.2 131.06 47.19 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -134.46 26.15 3.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.483 1.513 . . . . 0.0 108.92 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.16 -111.15 0.27 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -154.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -160.83 162.72 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.342 1.857 . . . . 0.0 106.258 -175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m 146.13 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 130.106 3.362 . . . . 0.0 108.837 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.6 p -81.23 -49.76 10.38 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.758 0.423 . . . . 0.0 111.227 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.36 -44.63 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -61.08 -33.38 73.24 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.81 -15.21 8.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -159.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.8 t -68.05 121.21 79.06 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 118.025 0.375 . . . . 0.0 111.896 -165.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -60.65 -11.47 17.45 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.461 2.774 . . . . 0.0 115.183 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.1 52.37 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -3.81 85.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 130.56 3.544 . . . . 0.0 114.315 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.4 t -142.18 -122.82 0.1 Allowed 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 116.595 -1.669 . . . . 0.0 109.356 158.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp 76.24 133.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 120.704 1.593 . . . . 0.0 107.713 -173.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -143.54 178.96 7.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.548 0.69 . . . . 0.0 111.467 -167.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 144.31 28.98 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.327 1.451 . . . . 0.0 109.52 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.9 -163.2 20.38 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 165.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -57.6 -63.45 1.23 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.593 1.557 . . . . 0.0 110.839 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.03 -55.75 2.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.547 0.739 . . . . 0.0 110.554 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.3 pt20 -103.93 -173.97 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.948 1.299 . . . . 0.0 110.064 -166.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -97.7 157.53 16.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.671 0.388 . . . . 0.0 111.402 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -125.39 172.25 9.78 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.221 2.209 . . . . 0.0 110.703 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.67 131.06 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.867 1.267 . . . . 0.0 108.04 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.22 94.15 0.05 OUTLIER Pre-proline 0 N--CA 1.452 -0.343 0 C-N-CA 127.693 2.397 . . . . 0.0 110.294 164.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -89.61 47.64 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 107.881 -1.623 . . . . 0.0 107.881 -171.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -159.85 -52.77 0.06 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 127.111 2.165 . . . . 0.0 106.93 -152.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.2 t -68.95 -45.19 80.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.693 160.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.4 t -51.05 127.79 19.88 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.35 -0.47 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.538 1.135 . . . . 0.0 113.693 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 8.7 m-20 65.42 97.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 127.492 2.317 . . . . 0.0 109.186 -168.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.1 169.84 17.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.439 0.696 . . . . 0.0 109.337 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.47 35.63 4.54 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.315 0.483 . . . . 0.0 112.715 -171.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 -69.92 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.074 0.937 . . . . 0.0 110.21 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 27.1 p -53.11 -42.92 66.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.233 1.013 . . . . 0.0 111.14 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -40.85 -51.55 3.14 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.575 1.55 . . . . 0.0 111.672 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.37 -46.03 61.39 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.427 0.291 . . . . 0.0 110.426 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.48 -37.62 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 53.1 t -59.82 127.76 85.77 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.875 -173.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.52 122.45 7.84 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.759 2.306 . . . . 0.0 111.793 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t 60.63 19.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.486 1.114 . . . . 0.0 111.735 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 p 43.85 54.27 5.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.187 1.395 . . . . 0.0 110.506 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.97 -34.34 65.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.14 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 99.5 mt -68.46 115.17 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -129.65 152.32 49.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.449 1.099 . . . . 0.0 109.687 178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -70.03 143.03 52.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -53.36 -20.88 4.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.29 -60.51 2.19 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.574 0.749 . . . . 0.0 109.669 171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -61.23 -36.46 80.02 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 127.595 2.358 . . . . 0.0 110.293 -173.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 68' ' ' ILE . 3.2 t -49.28 129.74 17.14 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.52 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -63.52 145.54 92.09 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.679 1.586 . . . . 0.0 109.534 176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -44.12 -46.63 8.78 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 127.113 2.165 . . . . 0.0 111.357 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.36 -53.07 1.53 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.463 . . . . 0.0 111.612 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -94.47 0.43 55.35 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.625 1.57 . . . . 0.0 112.651 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -23.45 65.11 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.841 -1.162 . . . . 0.0 110.153 168.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -47.96 -61.11 2.13 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.131 1.372 . . . . 0.0 110.462 166.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -54.86 -40.34 69.59 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 123.275 0.63 . . . . 0.0 111.42 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' HA ' HG11 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -61.56 -49.93 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -59.97 -32.37 70.77 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.776 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -63.74 -51.85 63.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.923 1.238 . . . . 0.0 111.749 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -55.8 -44.72 78.08 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.433 -0.792 . . . . 0.0 109.124 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ttm-85 -57.03 -39.99 75.85 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 122.032 -0.417 . . . . 0.0 110.766 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -63.17 -52.1 63.77 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 124.495 1.118 . . . . 0.0 109.44 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -50.97 -49.88 59.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 126.14 2.15 . . . . 0.0 110.648 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -110.11 44.21 1.26 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.879 0.872 . . . . 0.0 110.718 -169.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -150.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.069 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.426 -1.673 0 C-N-CA 131.673 3.989 . . . . 0.0 104.465 -169.419 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.508 ' HB1' ' SG ' ' A' ' 39' ' ' CYS 2.319 . . . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -114.47 123.4 49.31 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.34 1.856 . . . . 0.0 106.503 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 68' ' ' ILE . 2.9 t -138.68 159.43 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 122.43 1.11 . . . . 0.0 111.254 -156.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 HD21 ' A' ' 71' ' ' ASN . 1.6 tp -62.6 157.67 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.922 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.4 p -140.3 170.38 15.92 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 159.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -18.64 -64.61 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 128.211 2.604 . . . . 0.0 114.696 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.34 -23.58 24.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.005 1.803 . . . . 0.0 116.05 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -65.24 -31.37 72.5 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 121.323 1.874 . . . . 0.0 111.49 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.1 mt -48.57 127.22 3.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 C-N-CA 124.547 1.139 . . . . 0.0 111.608 -166.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.87 -7.46 55.22 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.288 1.899 . . . . 0.0 111.225 -170.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.9 m 54.29 46.05 25.98 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.542 1.171 . . . . 0.0 108.118 -172.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.44 19.14 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.234 0.828 . . . . 0.0 113.234 -156.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -126.81 -88.12 0.57 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.698 0.799 . . . . 0.0 109.554 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.59 -106.89 0.09 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.649 0.38 . . . . 0.0 110.34 -170.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.7 p -165.37 143.13 5.97 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.3 p -130.0 4.32 4.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.548 1.939 . . . . 0.0 110.783 -173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -81.07 -48.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.198 -0.939 . . . . 0.0 110.575 -172.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -61.65 -17.71 56.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.993 1.717 . . . . 0.0 113.15 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 m -93.31 -23.96 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.481 0.712 . . . . 0.0 112.74 -174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.7 t -71.86 120.9 82.75 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 118.753 0.706 . . . . 0.0 111.998 -161.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.22 -28.33 5.51 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.751 3.634 . . . . 0.0 115.527 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.55 25.06 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.762 0.825 . . . . 0.0 110.476 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 70.64 -32.78 0.25 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 162.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 58.2 m -82.92 56.17 3.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -152.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.9 127.93 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 153.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -124.42 175.04 7.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 108.19 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -102.9 148.3 25.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.31 -144.34 6.25 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 165.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -64.82 -64.55 0.84 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.309 1.044 . . . . 0.0 110.724 -168.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -102.12 -63.65 1.13 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.739 1.616 . . . . 0.0 108.178 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.47 176.5 6.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.39 1.09 . . . . 0.0 111.298 -173.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -91.4 157.64 16.97 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.238 -1.347 . . . . 0.0 107.886 172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -127.56 175.52 8.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.769 1.628 . . . . 0.0 107.912 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -131.76 142.72 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -80.87 107.12 6.65 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 164.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -79.16 -4.06 13.55 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 120.973 1.116 . . . . 0.0 113.232 -173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.71 -32.63 11.29 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.99 -49.6 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 165.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.508 ' SG ' ' HB1' ' A' ' 1' ' ' ALA . 29.0 t -54.23 132.42 43.43 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.67 28.74 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -167.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 1' ' ' ALA . 15.1 m-20 48.27 52.43 13.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.002 0.906 . . . . 0.0 110.815 -168.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -169.94 2.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.233 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.79 -127.24 3.12 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 75.76 -60.67 0.49 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.899 2.08 . . . . 0.0 110.799 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 26.5 p -53.5 -51.86 61.44 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.774 0.83 . . . . 0.0 110.379 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.84 -47.34 4.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.629 1.972 . . . . 0.0 114.184 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.12 80.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.439 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.1 m -79.92 -33.85 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.852 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.9 t -54.75 110.42 2.15 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -54.87 -43.58 57.91 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.62 2.213 . . . . 0.0 114.124 -166.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -90.85 0.28 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 122.907 0.483 . . . . 0.0 111.201 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m 47.19 55.45 8.1 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.463 1.105 . . . . 0.0 110.614 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.6 -27.55 66.14 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.56 1.144 . . . . 0.0 110.439 171.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.83 108.96 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.36 151.49 46.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 111.14 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -75.31 140.29 43.01 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.651 0.78 . . . . 0.0 110.337 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -39.64 -40.26 0.87 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.904 1.682 . . . . 0.0 113.373 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -64.74 -59.97 3.63 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.485 0.714 . . . . 0.0 109.5 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -61.44 -34.95 76.27 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.426 2.69 . . . . 0.0 110.486 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -51.07 125.22 23.11 Favored Pre-proline 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.616 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -57.96 148.0 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.851 1.7 . . . . 0.0 110.016 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -47.76 -44.21 27.99 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 126.755 2.022 . . . . 0.0 111.771 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -42.99 -48.98 6.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.781 0.832 . . . . 0.0 111.177 170.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -99.46 -3.94 32.5 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.604 1.562 . . . . 0.0 113.312 -172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -51.05 -32.36 21.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.276 159.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 m -51.62 -54.88 23.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.757 167.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -61.8 -39.32 91.31 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.542 -0.724 . . . . 0.0 110.306 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.404 ' HA ' HG11 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -60.96 -46.61 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.786 179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -57.97 -38.65 76.42 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 118.882 -0.58 . . . . 0.0 109.997 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -58.7 -55.98 28.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.869 0.759 . . . . 0.0 112.434 175.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.414 HD21 HG22 ' A' ' 4' ' ' ILE . 4.2 m-80 -50.38 -40.44 49.58 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.754 0.822 . . . . 0.0 111.331 173.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 mtt-85 -60.35 -59.04 6.04 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.263 171.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -29.37 67.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.745 1.618 . . . . 0.0 111.888 -170.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -47.04 -48.34 22.22 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.86 168.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -119.51 -9.44 9.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -169.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -72.14 -40.25 68.19 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.765 1.626 . . . . 0.0 110.526 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.561 2.344 . . . . 0.0 106.878 169.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.61 128.04 48.07 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.728 0.811 . . . . 0.0 109.347 -177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.53 158.62 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 122.314 1.054 . . . . 0.0 110.106 -164.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.504 HG22 HD21 ' A' ' 71' ' ' ASN . 2.1 tp -64.07 159.47 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.889 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 p -138.78 170.32 16.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 157.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -18.14 -65.77 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 128.396 2.679 . . . . 0.0 115.167 168.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.67 -26.28 29.2 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.783 2.322 . . . . 0.0 116.916 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.0 t -66.18 -30.6 71.1 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.004 1.275 . . . . 0.0 110.977 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.6 mt -45.21 123.82 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 111.071 -174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.1 -32.11 2.53 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.342 0.972 . . . . 0.0 112.543 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -74.91 69.97 1.92 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.818 1.247 . . . . 0.0 109.613 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -74.64 78.74 2.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.594 0.758 . . . . 0.0 110.603 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -85.06 -159.68 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 168.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.63 -4.79 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.558 1.943 . . . . 0.0 111.766 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.4 m -57.56 -42.29 82.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.119 -0.988 . . . . 0.0 112.598 -172.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' O ' HG22 ' A' ' 19' ' ' VAL . 27.5 p -71.68 -51.94 20.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.089 0.404 . . . . 0.0 111.205 -177.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 p -48.79 -46.09 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -64.05 -26.1 68.41 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 16' ' ' CYS . 6.1 m -84.32 -21.31 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -160.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 25' ' ' ILE . 51.4 t -69.17 116.11 38.79 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -161.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -54.08 -21.58 22.32 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.469 2.779 . . . . 0.0 114.088 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.84 25.38 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.095 0.958 . . . . 0.0 110.224 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 74.18 -42.29 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.264 1.826 . . . . 0.0 114.292 165.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.4 t -75.58 70.19 2.38 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -160.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 20' ' ' CYS . 2.7 mp -108.13 107.82 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 138.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.463 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 1.1 p80 -106.61 174.48 5.87 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 123.572 0.749 . . . . 0.0 109.158 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -95.89 139.25 32.37 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.003 -0.435 . . . . 0.0 110.436 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.5 -139.31 9.39 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 165.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.48 -67.03 0.47 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.496 1.118 . . . . 0.0 110.632 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.38 -70.01 0.76 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.82 1.248 . . . . 0.0 107.817 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -84.8 176.01 8.78 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.088 0.955 . . . . 0.0 111.22 -173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -82.95 159.87 22.18 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.753 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -132.23 172.52 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.012 1.725 . . . . 0.0 107.787 173.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mt -126.47 157.4 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -98.79 106.87 40.0 Favored Pre-proline 0 C--O 1.235 0.335 0 CA-C-N 119.408 1.003 . . . . 0.0 108.892 158.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.11 -22.52 70.12 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.573 1.515 . . . . 0.0 113.146 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -78.39 -21.74 48.89 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 119.905 1.229 . . . . 0.0 111.145 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.46 -45.81 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -51.84 136.96 27.18 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.592 0.757 . . . . 0.0 111.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.17 21.03 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.231 1.012 . . . . 0.0 112.201 -176.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 46.53 57.54 5.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.601 1.16 . . . . 0.0 109.518 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 2.2 p -76.54 -150.56 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.272 1.029 . . . . 0.0 110.313 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.32 43.44 0.18 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 120.419 -1.425 . . . . 0.0 113.433 160.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.19 -14.24 0.4 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 147.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . 0.28 3.3 p 40.8 35.57 0.34 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.915 0.886 . . . . 0.0 110.242 -162.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -96.38 -67.22 0.86 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.28 -33.02 57.71 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.69 0.796 . . . . 0.0 112.099 -174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.7 m -74.0 -28.15 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.276 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.2 116.84 52.93 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -53.6 -37.05 82.92 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.847 2.365 . . . . 0.0 112.366 -176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.78 -18.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 123.912 0.885 . . . . 0.0 110.665 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 m 50.1 54.4 11.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.887 0.875 . . . . 0.0 110.109 -168.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.72 -30.88 28.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.064 1.745 . . . . 0.0 110.297 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 34.6 mt -68.62 121.87 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -134.71 153.68 51.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.843 1.257 . . . . 0.0 111.187 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -73.17 146.24 45.74 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.193 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -47.49 -33.87 6.77 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.8 1.24 . . . . 0.0 113.108 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.41 -58.27 3.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.504 0.722 . . . . 0.0 109.759 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -61.01 -35.19 76.19 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.401 2.681 . . . . 0.0 109.958 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.99 125.71 11.17 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.924 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.61 152.78 66.25 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.911 1.741 . . . . 0.0 110.878 -176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -49.15 -41.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.178 1.391 . . . . 0.0 113.297 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.56 -55.27 9.57 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 122.933 1.349 . . . . 0.0 108.863 170.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -90.83 -0.37 57.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.337 1.055 . . . . 0.0 113.758 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -50.25 -30.68 12.23 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.428 -0.795 . . . . 0.0 109.43 154.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 m -55.96 -50.06 71.83 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.596 -0.69 . . . . 0.0 111.82 171.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -64.42 -38.13 89.94 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.69 -45.3 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.491 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -54.9 -35.97 64.69 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.7 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -66.23 -55.73 14.77 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.079 1.309 . . . . 0.0 112.701 175.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.504 HD21 HG22 ' A' ' 4' ' ' ILE . 3.8 m-80 -50.81 -39.12 52.18 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.285 -0.885 . . . . 0.0 111.415 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -60.73 -63.1 1.42 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -39.24 -52.11 1.97 Allowed 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.588 1.955 . . . . 0.0 111.438 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -43.33 -35.0 1.36 Allowed 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.074 2.149 . . . . 0.0 113.175 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CZ ' ' CD2' ' A' ' 26' ' ' HIS . 92.3 m-85 -121.03 14.47 11.47 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.72 -36.09 3.24 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.868 0.467 . . . . 0.0 111.295 -170.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.864 -152.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.15 130.33 39.03 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.629 1.172 . . . . 0.0 108.276 174.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 68' ' ' ILE . 44.4 t -129.82 150.07 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 122.436 1.112 . . . . 0.0 109.288 170.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.707 HG22 HD21 ' A' ' 71' ' ' ASN . 2.8 tp -63.8 165.12 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.286 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -118.52 -88.21 0.62 Allowed 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.65 -51.47 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 123.854 0.721 . . . . 0.0 111.44 -149.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -56.93 -5.9 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 N-CA-C 116.752 1.789 . . . . 0.0 116.752 172.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.69 -31.87 67.23 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.676 1.58 . . . . 0.0 110.398 170.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 31' ' ' GLN . 11.8 mt -49.5 113.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.366 0 C-N-CA 123.613 0.765 . . . . 0.0 112.778 -169.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.08 4.81 23.63 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.199 1.38 . . . . 0.0 114.265 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.8 m -69.83 -46.08 66.4 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 119.155 1.478 . . . . 0.0 110.961 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -161.13 163.91 31.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -70.92 -174.7 0.98 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.919 1.288 . . . . 0.0 109.247 162.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -21.43 117.63 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.729 2.412 . . . . 0.0 114.066 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB2' ' S4 ' ' A' ' 78' ' ' F3S . 4.0 m -149.05 -37.41 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.534 0.734 . . . . 0.0 112.41 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.4 p -106.61 23.26 14.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 112.158 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -56.26 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.826 -1.172 . . . . 0.0 109.861 -175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.94 -21.27 7.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.948 2.099 . . . . 0.0 113.108 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.3 m -84.21 -27.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.365 1.066 . . . . 0.0 112.997 -177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -80.68 122.62 82.43 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 119.104 0.865 . . . . 0.0 111.816 -164.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.89 -26.63 7.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 124.463 3.442 . . . . 0.0 116.128 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.0 m -119.06 15.9 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.809 0.844 . . . . 0.0 111.931 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 57.55 11.43 1.24 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.373 1.469 . . . . 0.0 114.557 167.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 21.0 p -84.28 22.55 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.327 -1.483 . . . . 0.0 114.329 -161.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.19 124.1 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -129.78 179.62 5.74 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.86 1.664 . . . . 0.0 107.979 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -105.6 148.71 27.01 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.476 0.31 . . . . 0.0 110.676 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.56 -138.79 5.28 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 165.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mp0 -65.21 -67.71 0.42 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.188 0.995 . . . . 0.0 111.21 -164.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -136.58 30.2 2.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.806 1.642 . . . . 0.0 108.299 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 9' ' ' ILE . 9.0 tt0 -160.22 149.52 17.53 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -163.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -94.82 156.3 16.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.96 174.91 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.3 mp -133.44 150.07 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -87.54 110.11 31.66 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 119.065 0.848 . . . . 0.0 109.843 158.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.01 -4.96 12.87 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.608 2.205 . . . . 0.0 113.478 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -88.97 -35.2 16.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 120.037 1.29 . . . . 0.0 108.718 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.9 t -72.19 -47.66 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 123.536 0.735 . . . . 0.0 109.677 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.2 t -49.49 120.92 4.51 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -75.33 16.8 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t0 60.5 66.0 0.99 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.258 2.223 . . . . 0.0 109.636 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -121.93 -160.37 0.87 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.379 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.98 -130.19 3.0 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 76.04 -59.03 0.52 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.615 1.966 . . . . 0.0 111.155 173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 21.0 p -47.02 -39.68 13.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.047 1.339 . . . . 0.0 110.563 173.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -19.79 -58.09 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.024 2.13 . . . . 0.0 114.267 160.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.85 78.88 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -161.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.4 m -79.02 -27.35 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -165.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -68.07 115.6 30.28 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 118.261 0.482 . . . . 0.0 111.826 -166.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -63.66 -39.03 37.07 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.377 2.052 . . . . 0.0 111.886 -172.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.8 t -115.2 50.51 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.7 m -2.83 72.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 128.801 2.84 . . . . 0.0 116.34 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.65 -18.94 39.27 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.949 2.1 . . . . 0.0 110.328 171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -63.23 110.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.159 1.383 . . . . 0.0 109.466 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -137.51 153.75 49.97 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.42 0.629 . . . . 0.0 112.079 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -77.37 146.51 36.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -46.68 -37.25 8.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.362 1.065 . . . . 0.0 113.458 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.0 -51.44 32.41 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.344 1.058 . . . . 0.0 110.13 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.41 -38.64 84.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.039 2.136 . . . . 0.0 109.897 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 68' ' ' ILE . 2.5 t -49.82 123.27 14.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.22 151.79 83.03 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.321 1.347 . . . . 0.0 109.329 -171.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -43.26 -44.86 5.56 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.136 2.175 . . . . 0.0 112.542 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -42.09 -45.78 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.995 1.318 . . . . 0.0 112.224 169.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -107.39 6.64 28.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.548 1.939 . . . . 0.0 113.4 -177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HA ' HD13 ' A' ' 68' ' ' ILE . 32.1 mmtm -52.28 -33.2 40.9 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.411 1.46 . . . . 0.0 109.965 169.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -41.73 -47.53 4.05 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.989 2.116 . . . . 0.0 112.913 168.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -64.31 -25.64 68.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.646 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.577 ' CD1' HG11 ' A' ' 60' ' ' VAL . 1.8 mp -64.24 -51.65 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -56.06 -35.98 67.55 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.322 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -68.46 -56.98 6.57 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.577 1.08 . . . . 0.0 113.166 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.707 HD21 HG22 ' A' ' 4' ' ' ILE . 7.0 m-80 -51.66 -41.39 61.33 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.423 -0.798 . . . . 0.0 111.339 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.7 mtt-85 -56.75 -62.21 1.9 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 170.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -42.07 -53.53 3.91 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.679 1.592 . . . . 0.0 111.106 -174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -44.05 -37.57 3.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.655 1.982 . . . . 0.0 112.352 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -122.13 21.14 10.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.114 0.566 . . . . 0.0 111.67 -173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 -34.86 3.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.212 1.005 . . . . 0.0 111.271 -179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HZ2' ' HB3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.674 -1.632 . . . . 0.0 107.363 -153.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' F3S . . . . . 0.478 ' S4 ' ' HB2' ' A' ' 15' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_